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whole "Body Moaitoring and In Vivo Aotiyation 
ihmlys:^8 ia Nuclear .M ,
by
Keith Boddy, M.Bo#
l’Ile tîiosie doseribo0 the development and application of ti-îo 
new teohniqnes in nuclear modlqine# % e  first involves a 
fundamentally different approach to the attainment of high 
sensitivity using a whole*btxly monitor. It represents a 
significant advance on axiating' methods* Iho second technique, 
in vivo activation analysis of iodine in the thyroid gland, 
apparently has not been reported previously# It may prove an 
important clinical tool for diagnosis and research since a 
knowledge of the total iodine content of the thyroid will 
provide a better understanding of the aetiology of itc associated 
diseases# Ho other technique can ovidexvhly provide this data.
il jiew design of viiole^ b^ody monitor has been developed 
utilising a shadow shield weighing 7*8 tons compared with 
conventional shields of 80v50 tons. Construction of the 
prototyx>e ‘monitor and an assessment of its porfo.tmm'vce load 
to the conclusion that sensitivity at least comparablo viith 
ihat of the conventional monitor should be attainable. ïîxe 
significant reduction in shicdd weight facilitates the in* 
corporation of this design of monitor in a mobile laljoratory# 
Clinical studies of iron metaJjolisra and of vitamin metabolism 
have been carried out using the prototy^^e monitor.
liie avmxd of a research grant by the Scottish Hospital 
Kndovmieuts Besearch Trust enabled the construction of a high 
sensitivity Biobile x#iolo-bcxiy monitor (MBBLIH). Its
pGrfojctaaiTce is sûiovm to be better than most conventional monitors 
and at least ccmiparable with the remainder. Apart from the 
advantage of mobility, the monitor can be used as an installed 
monitor capable of incorporation in almost any existing lal->oratory. 
llte sensitivity can he easily varied to meet individual requirOTonts 
t'itile the cost of an installed high sensitivity monitor, with a 
lOO-channel pulse height analyser# aan Ijq less than £6,600, Camaeroial 
conventional moziitors cost about £20,000 * £30,000 excluding transport 
and erection costs and the cost of a separate building if this is 
necessitated, The mobile monitor is now being used for medical 
research in collaboration ifith hospitals in Scotland,
Â new technique has been developed to measure in vivo the total 
iodine content of the thyroid gland using activation analysis, Tîte 
principle of the methW is to irradiate the patient thyroid in vivo 
using a collimated bean of neutrons from the h,T,R, 100 reactor, Tlie 
iodine*128 induced by the neutron irradiation is then measured using a 
suitably shielded scintillation counter m d  pulse height analyser, 
FoXloîclng prelimiucîry experiments, including in vitro raeasurements 
on excised glands, the techniques were adapted for clinical use,
A high sensitivity shadow*shielcled thyroid monitor was designed 
and constructed for clinical trials#
The results of the clinical trials liave led to improvements 
in the technique in the light of this experience, Tltese modifications 
ai*e being incoiporated and further in vitro measixrements made before 
the tecîinique is used as a diagnostic and research tool.
(1 1 )
PREFACE
Tills thesis contains an account of research conducted by 
the author at the Scottish Research Reactor Centre, East Kilbride 
and at the University of Glasgow» The development and the present 
situation and requirements of whole-body monitoring and of the need 
to measure the total iodine content of the thyroid gland to achieve 
a better understanding of the aetiology of associated diseases are 
considered* Solutions for these separate problems are proposed. 
(Chapter 1)« Experimental investigation of the proposed solutions 
and their clinical application is the subject of the thesis«
The conception, design and responsibility for the construction 
and assessment of the performance of the prototype whole-body 
monitor (Chapter 2) and of the mobile monitor (Chapter 3) are 
entirely those of the present author- The clinical studies of 
aspects of iron metabolism (Chapters 4 and 5) and of vitamin 
metabolism (Chapters 6 and 7) were undertalcen in collaboration 
ifith Dr, G- Will, Royal Infirmary, Glasgow, and with Dr«J«F„ Adams, 
Southern General Hospital, Glasgow, respectively. The analysis of 
the results and their interpretation, as presented here, are those 
of the present author.
The possibility of measuring the total iodine content of the 
thyroid gland by in vivo activation analysis was realised by the 
author. Dr. W.D« Alexander and Sir Edward Wayne, Western 
Infirmary, Glasgow. Preliminary experiments and development of 
the technique (Chapter 8), including the design and construction
(i)
of the shadow-shield thyroid monitor (Chapter 9), were the author's 
responsibility- Clinical trials (Chapter 10) were conducted in 
collaboration with Dr. W.D, Alexander- The analysis of the results 
and their present interpretation are those of the author.
(ii)
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CHAPTER Is înt roduat ion :
Tv/o techniques vjhich have been introduced into nuclear 
medicine only in recent years are whole-body monitoring and 
in vivo activation analysis. The initial stimulus for the 
development of "(da ole-body monitors was radiological protection 
measurements of internal contamination. The historical 
development of the monitors and the improvements in sensitivity 
are summarised in Table 1.1 (after Spiers, 1962). Probably 
the first international symposium at which a collection of papers 
dealing with the clinical application of whole-body monitors was 
presented was held as recently as 1961 (I.A.E.A. Symposium on 
VJhole-Body Counting, Vienna, 1961). The first reports on in 
vivo activation analysis were even more recent (Anderson et al.,
1964) by the present author (7'bh International Symposium on 
Radioactive Isotopes in Clinical Medicine and Research, Bad 
Gastein, January, 1966).
1.1 Whole-body monitoring:
The applications of whole-body monitors in nuclear 
medicine can be roughly classified into two groups, routine 
clinical measurements, for example of absorption of labelled 
iron or vitamin in the diagnosis and treatment of iron 
deficiency anaemia or of pernicious anaemia, and research 
investigations which may require the measurement of body 
potassium-40 to provide an estimate of total body potassium 
or lean body mass or of the long-term turnover of slower 
metabolic compartments of the body. Routine clinical measure­
ments usually require a comparâtively simple and inexpensive 
monitor, (Veoll, 1962, Hin© et al., 1962, Warner and Oliver, 1366).
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since the quantity of isotope administered is generally determined 
by less sensitive measurements carried out simultaneously such as 
those of serum, plasma or urine specific activities* These 
monitors are very valuable since the losses, inconvenience and 
inaccuracies of urine and faecal monitoring may be obviated as well 
as the consequent hospitalisation of the patient and its associated 
expense. Conventional high sensitivity monitors, on the other 
hand, are usually expensive and elaborate. Rooms of lead, steel 
or excavated from chalk subsoil have been utilised to reduce the 
background counting-rate. Commercial high sensitivity monitors 
cost about £20, 000 - £30,000 excluding transport and erection of 
the steel room. These rooms are constructed from pre-1945 naval 
steel and since their weight is from about 26-50 tons, a special 
building may be necessitated to house the monitor. Despite these 
drawbacks, the temptation exists to consult a catalogue without 
careful consideration of the exact requirements of, or of the 
justification for, such a monitor. Spiers (1962) asked "IVhat 
is the cheapest form of a total body potassium monitor for 
clinical work. - can it be obtained for the price of a high-duty 
diagnostic X-ray set, say US $ 15,000?“ and commented (Spiers,
1965) "The development (of whole-body monitors) has been rapid 
and today there are many more whole-body counters than there 
are thorough and comparable analyses of their performance*
The choice of available apparatus is large and the cost variable 
but considerable*" Similar considerations were the stimulus 
for the present studies which describe the development of a new 
design of \diole-body monitor, which can be adapted to meet a 
prescribed sensitivity and the higher sensitivity of Vnich is 
at least as good as that of most steel room monitors. The cost 
can be loss than £6, 500 >?hich is comparable with the figure 
suggested by Spiers. Clinical studies described show that
-  2 —
ultimate sensitivity is not an essential pre-requisite for the 
prosecution of useful clinical research.
The present work began because no hospital in Scotland 
(in 1963) possessed, or had easy access to, a whole-body monitor 
of high sensitivity. The high capital cost of an installed 
conventional unit and the difficulties of transferring patients 
to a centralised facility argued against its establishment. It 
was considered that with a new design of monitor, high sensitivity 
might be attainable in a comparatively lightweight shield thus 
enabling the monitor to be incorporated in a mobile laboratory.
As many clinical applications can be dealt xd.th adequately by 
simple whole-body monitors, it was felt that if a high sensitivity 
monitor was available for the fewer investigations requiring such 
sensitivity, a mobile whole-body monitor might fulfill this need, 
VJhile meeting the requirements of several hospitals as a mobile 
unit, the monitor design would ideally be suitable also as an 
installed monitor of high sensitivity and low cost.
1.2 Selection of design for investigation.
The choice of design to be investigated was limited in 
view of the ultimate aiia of providing a mobile monitor. It was 
clear from the outset that significant reductions in shield weight 
could be achieved by concentrating shielding around the detector(s). 
By its nature, the steel or lead room must be sufficiently large to 
accommodate the patient so that although the total weight of shield­
ing material is large, it can only reduce the background counting- 
rate of the detectors to that which would be obtained if each 
detector was surrounded by close fitting steel or lead of the same 
thickness as the room walls etc.
It was also apparent that to shield a single detector of large 
voluniG is simpler and more economical in weight than to shield a 
multiple-crystal system of the same total crystal volume. There 
are, however, other advantages in the use of a single crystal rather
than multiple crystals. For example, Killer (1962) points to 
greater ease and speed of operation since only one crystal needs 
to be calibrated, while counting-rates are equal or higher in the 
photopeak and considerably lower at lower energies than those 
observed with multiple-crystal arrays of the same total crystal 
volume, as shown in Fig, 1,1 The multiple-crystal array requires 
relatively complex mixing and gating electronic circuits either to 
add the various crystal outputs into one composite spectrum or to 
store the output of each crystal into different sections of the 
memory of the analyser. The possibility exists also of a shift 
in energy calibration of one of the multiple crystals leading to 
spectrum distortion. Probably the main advantage of the multiple- 
crystal geometry is that something can be learned of the distribution 
of the isotope in the body if the individual outputs of the crystals 
are sorted and recorded separately using either single channel 
analysers or separate sections of the analyser memory. If the 
single crystal is used to scan the patient, say, by passing the 
patient beneath the detector, this advantage no longer applies 
only to the multiple-detector system,
1,3 In vivo activation analysis;
Keasuremiont of the total body content in- vivo of a given 
element such as sodium or chlorine is usually not possible using 
existing techniques. An obvious exception, as mentioned earlier, 
is the estimation of total body potassium by measuring the potassium- 
40 content in a whole-body monitor. Isotope dilution studies provide 
an estimate of only the exchangeable fraction of the element and depend 
on the extent to which, and how rapidly, equilibrium between body 
compartments is established. In some cases the total body content 
of an element and the exchangeable fraction are similar as shown, 
for example, by comparison with analysés of cadavers.
Neutron activation analysis has found wide application in 
vitro in medicine and biology. Exposure of many elements to neutron 
irradiation causes their transformation to radioactive isotopes,
-  4 —
Using appropriate techniques, the radioisotope(s) can be identified 
and the quantity of the corresponding target element(s) estimated. 
Chemical separation is a common first step after irradiation to 
eliminate radioactivity from irrelevant and unwanted radioisotopes 
produced incidentally. However, separation is often neither
feasible nor complete. The principal interfering isotopes
following irradiation of biological material, vjhether serum, urine 
or tissue, are usually sodium-24 and chlorine-38 which are difficult 
to eliminate while lengthy separation procedures' cannot be used 
when the isotope of interest (e.g. ^Vig, ^^Ca etc.) has a
comparatively short half-life- Two properties characteristic of 
the isotope, its rate of decay and the type and energy of the 
radiation it emits, may make analysis possible even in these cases. . 
Sequential measurement of the disintegration rate or radiation 
spectrometry, such as gamma-ray spectremetry, can be used to estimate 
separately but simultaneously the quantities of various elements 
present in the same sample.
Several accidents resulting from unexpected criticality in 
nuclear reactors or reactor assemblies have resulted in over­
exposure of humans to neutrons. Radioactivity, particularly 
sodium-24, was consequently induced in elements of idiich the body is 
composed. These exposures, being accidental, involved neutron 
(and gamma) doses' in the lethal or ranges. However, using a
high sensitivity whole-body monitor to measure the induced activities 
and a controlled exposure to neutrons, the measurement of whole-body 
sodium and other elements can be achieved with doses of less than, 
or similar to, those of accepted procedures such as an abdominal 
radiograph (about 3 reiu, I.C.R.P., 1960).
VJhole-body neutron activation analysis in man in vivo using 
a neutron generator' has been recently reported (Anderson J. et al. 
(1964)) in the investigation of the normal body content of sodiuxi, 
chlorine and calcium involving total-body doses of about 1 rem.
The major experimental difficulty was to produce a uniform neutron
— 5 —
flux throughout the body xfaich represents a large hydrogenous 
sample. A further problem which has not been over-emphasised 
in this work is that of changes in the neutron spectrum due to 
moderation and capture of neutrons. This is of importance as 
the neutron capture cross-section of an element varies with 
neutron energy « Both of these factors may prevent each nucleus 
having an equal probability of transformation, which, strictly, 
is an essential criterion.
Interpretation of the results presented sane difficulty 
because of the many different chemical elements of which the 
body is composed. Each of these elements may produce one or 
more radioactive, isotopes as a result of neutron irradiation.
The relative amounts of the isotopes produced depends upon the 
quantity of the stable element in the body, cross-section of 
the element, etc. so that the resultant gamma spectra may 
contain significant contributions from isotopes which are not 
pertinent to the investigation in hand. An example of this 
interference was the 0.51 MeV peak in the spectra obtained for 
the two human subjects reported* This peak was attributed to 
the annihilation radiation due to positron emission by nitrogen- 
13 produced by. the (n, 2n) reaction. A computer programme 
carrying out spectrum-stripping with least squares fit analysis 
simplified the interpretation in this study,
1.4 In vivo activation analysis of iodine in the thyroid gland;
Direct measurement in vivo of the intra-thyroidal iodine
stores has not, apparently, been made previously. Total thyroidal
iodine, up to the present, has been measurable only after excision
of the gland. Indirect methods in vivo, such as that described by
Nodine (1957) measure the intrathyroidal exchangeable iodine and
have marked limitations, Nodine*s method involves the administration-
of a tracer dose of iodine-131 followed nine days later by an injection
of thyroid stimulating hormone (TSH)• The resulting increases in the
131plasma-bound iodine (FBI) and PHI after twenty-four hours are
131measured* The increase in the PBÏ and PBI corresponds to
the newly released thyroid hormone vjhich is assumed to have the
same specific activity as the intrathyroidal exchangeable iodine
(lEI), If the thyroidal radioactivity is measured immediately
before the injection of TSH, IEI can be estimated since,
131
thyroid I activity = rise in PBI and, hence, 
lEI rise in PBI
1 31
lEI “ rise in PBI x thyroid I activity.
1 31
rise in PBI^^^
The difficulties in this technique include:-
1, The method fails when injection of TSH produces no effect as
in thyrotoxicosis, endocrine exophthalmos etc.
2, Only the "exchangeable" iodine is measured,
3, Any iodine vdiich has not equilibrated with the tracer dose in
nine days is not measured* This fraction may vary between
individuals*
4, The uptake by the gland of the tracer dose is influenced by 
the level of the intrathyroidal stores as well as the metabolic 
rate of the gland. For exaraple, the test does not differentiate 
between high uptake due to "depleted" stores, in idiich case the 
tracer does not, presumably, equilibrate v/ith "exchangeable" 
iodine, and that due to a high rate of metabolism. The converse 
situation is open to corresponding misinterpretations*
Data on the intra-thyroidal iodine stores may throw some light 
on the aetiology of non-toxic goitre* Ermans (1961) found that in 
goitrous patients from the Congo, the total iodine content of the 
thyroid gland was. normal. Values vdthin the normal range have been 
found also by Wayne et al (1964)* However, Wilson (1963) reports 
finding in patients with non-toxic goitre, that the iodine content of 
the gland may greatly exceed that found in nomal thyroids* This 
latter observation, if confirmed, would support the concept of an intra* 
thyroidal metabolic fault as opposed to dietary iodine deficiency.
— 7 -
A knowledge of the intra-thyroidal iodine stores is also of 
considerable practical importance since in its absence all radio­
iodine tests giving an estimate of the release of thyroid hormone 
from the thyroid gland (e.g. PBÏ-131) must remain on an empirical 
basis. Estimation of the intra-thyroidal stores is clearly not 
necessary in every case, but would be of particular value in those 
cases (about 5^/o) vtiere the radioiodine test was inconsistent with 
the clinical findings* Patients with a small intra-thyroidal pool 
could be distinguished from those with true over-secretion of thyroid 
hormone, both of which give a similar pattern of radioiodine release 
(Houtras et al,, 1981).
In vivo activation analysis of iodine in the thyroid gland
would estimate the total iodine content and not that of exchangeable
iodine. As the gland is close to the surface of the body, problems
of non-uniformity of a single irradiation should be less than in
irradiation of the total body* This is an important factor since
irradiation from both sides of the body was necessary to produce an
approximately uniform flux throughout the vfhole body (Smith, and
Osborne .1965 Private communication) and such a procedure might be
less appropriate for the thyroid. In particular, the flux of 14
KeV neutrons from a neutron generator, as used by Anderson et al.,
7 2is presently less than 10 n/cm sec* even at a distance of only
10 cm from the target. The thermal neutron flux may be at least
an order of magnitude less and a simple calculation suggests that a
7 2flux at least in the region of 10 n/cm sec is required. Such 
fluxes are obtainable from nuclear reactors with the reservation 
that the uncollided fission neutron energy spectrum shows that the 
maximum number of neutrons have energies of about 1 MeV. The 
problem of non-uniform irradiation may, therefore, be more acute 
than with neutrons of higher initial energies.
The method of irradiation, \diich implies the use of a 
collimated beam of neutrons limited to the area of the gland, is 
probably achieved more easily using a reactor beam tube or stinger
since the biological shield of the reactor should already be very
- 8 -
effective in confining emergent neutron and ganrua radiation to these 
regions.
With these factors in mind, the feasibility of utilising the 
UTR-10CK14 reactor at the Reactor Centre for in vivo activation 
analysis of iodine the thyroid gland was examined. Preliminary 
experiments wore conducted and a trial series of clinical measure­
ments were carried out. The results of these have been also 
reported elsewhere (Boddy, 1966). Improvements have been made 
in the techniques in the light of this experience and further 
clinical trials are imminent prior to the wider application of the 
technique.
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Ctli-\PTSR II; The Prototype Shadow Shield 'i Pa ole Pody >'onitor.
Tne ultimate aims in developing the prototype monitor tie re to 
provide a design capable of high sensitivity at low cost and tdiich 
could be incorporated in a mobile laboratory. As a static monitory 
it should be able to provide various degrees ox sensitivity according 
to individual requirements»
The criteria adopted were:
a) A comparatively lightweight shield with a-limit of about 7 tons 
for a cororaercial vehicle chassis.
b) High sensitivity viz. low background counting-rate and high 
counting-rate per unit activity or per gram of potassium.
c) iSmall variation of counting-rate due to the redistribution of 
isotopes in the body,
d) Reasonable cost*
Several possible designs were considered, the most promising of 
which seemed to be the use of a suitably shielded single detector 
beneath which the patient ifas passed* hath this configuration, the 
shield weight could be greatly reduced and redistribution effects 
might be minimised.
2*1 Equ ipment:
ho direct financial assistance was available for this work, 
so that materials and equipment originally acquired for other 
purposes were used with seme im.provi sat ions*
The largest available sodium iodide detector assembly had a 
3 inches diameter x 3 inches crystal* Lead was available largely 
as four-inches chevron bricks and was not of selected low background 
quality* Initially, a remote Laben 512-channel pulse height 
analyser was used until a 100-channel T.m.G* Gemmascope became 
available,
- n  -
2-2 Development of the shadow shield*
To obtain high sensitivity, the requirement was for a low 
background counting-rate. Hiller (1958) and Kay and Harinelli (1962), 
during the construction of a steel room whole-body monitor, obtained 
the background reductions shovm in Fig, 2*1. In the final shield, 
comprising' 20*3 cms* of iron and 3 rnms» of lead, the background counting- 
rate from 0„05 HeV to 1.5 HeV is reduced to between 1-4°/o of the
unshielded background counting-ratea These reductions depend to some 
extent on the initial conditions in which the unshielded background was 
determined as well as the potassium-40 and impurities contained in the 
cig’*stal assembly* For these reasons, the background reductions 
obtained by these authors could not be taken as an absolute guide for 
our different circumstances but, for a similar performance, the re­
duction in background required of the shadow shield could be assumed 
to be about 2 ^/o of the unshielded background.
Tile stages in the development of the prototype and the average 
background reductions attained are shown diagrammatically in Fig. 2.2. 
The final stage is shovna in Fig 2*3. Tlie results are summarised in 
Table 2.1 for the four energy ranges considered. These ranges were 
chosen since they covered approximately the principal photopeak 
energ'ies of most of the isotopes of medical interest.
The unshielded and final shield background spectra are shown in 
Fig 2.4*
The overall background reductions were very close to the target 
suggested from the data of Hiller and Hay and Harinelli* The 
largest reduction is for the I d  - 1*5 HeV range which includes the 
photopeak (1*46 HeV) of the naturally occurring potassium-40 isotope* 
This may be attributable to potassium-40 in the building materials 
of the floor, walls etc. producing a high unshielded counting-rate 
whilst the lower energy ranges may appear to be less well shielded 
because of scattered garma rays reaching the detector»
-12 -
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2H3 Description of the prototype:
The shield is 12 ft. 8 ins. in length, 3 ft. 4 ins. raaxir^ .nm 
width and 3 ft. 2 inches r.ioximniTi height. The detector in the central 
turret views the patient through a hole of 3^ inches diameter cut 
through the steel supporting plate, A bed, comprising a metal 
stretcher covered with polythene foam and rexine and with "idieels 
attached beneath, was motorised by means of a rotating screw 9 feet 
in length driven by a two-speed l/8th h.p. motor. Tne scan speeds 
are 2 ins per minute and 1 inch per minute. From the crystal 
face to patient mid-line is 9 inches.
In operation, the bed is manually de-coupled and set at the 
extreme limit of travel. The patient lying supine, and subsequently 
prone, rests the top of the head against a fixed head-rest defining 
the position with reasonable reproducibility- Counting is started 
automatically as a wheel passes over a micro-svritch fixed in the 
rails on which the bed runs and is stopped by an adjustable micro- 
switch set according to the patient’'s height. The patient's head 
is beneath the centre of the crystal when counting begins arid the 
feet when counting ends.
2.4 Performance of the prototype:
The performance of the prototype and its sensitivity, defined 
as the quantity of the isotope giving three times the standard 
deviation of the background in the same counting time (Trott, 1965), 
are summarised in Table 2.2.
2.6 Redistribution effects:
In addition to sensitivity, the results of patient monitoring 
may be influenced by redistribution of the isotope in the patient's 
body. The extent of this influence has been exariiined using point 
sources and water phantoms and also patients, A source of sodium-22 
was placed consecutively at points four inches apart along the long­
itudinal axis and at points three inches apart along the lateral axis
TABLE 2«2
Summary of the Performance of the Prototype Monitor,
Isotope
Energy
Range
(MeV)
Counting-rate _(cpm/uc) 
with patient or_|_ 
"active” phantom
Background (opm) 
with water 
phantom
Sensitivity (uc) 
for 30 min. 
scan.
- 59^ 1.0 - 1.38 550 18.4 4.1 X 10"3
0.4 - 1.38 1670 103 3.4 X  10"3
- 58^ 0.74 . 0.89 490 13.7 4.0 X  10"^
0.3 - 1.0 1800 112 3.2 X  10"®
- 57^ 0.035- 0.188 3430 330 2.9 X  10"®
- 1.36 - 1.56 0.03^ 8.0 M.
- 2 A 1.18 - 1.38 652 9.7 4.3 X 10"®
- isx'*' 0.3 - 0.42 1515 64.4 2.9 X  10 ®
5E cpm/gm ÏC
of the monitor at the height of the patient mid-line. Sources of 
caesium-137 and cobolt-60 were also placed at various depths in a 
water phantom directly below the crystal.
a) Longitudinal variation:
The results obtained in examining the longitudinal variation 
are summarised in Table 2.3
Mean values of both photopeak percentages are plotted against 
source position in Fig 2.5 and symmetry is assumed. Graphical 
integration gives the contribution over given distances of travel and 
these results are also shown on the same figure. It is apparent that 
counting along the longitudinal axis at this height is virtually 
confined within about 16 inches on each side of the detector mid-line.
An estimate can be made of the variation in the whole-bcdy count 
and the differential count due to different sections of the body as a 
function of the position of starting and stopping counting. It is 
assumed that the activity is uniformly distributed at points four 
inches apart along the body (of dimensions after Bush (1946)} 
commencing four inches from the top of the head to four inches from 
the feet as shown in Fig, 2.6. The integrated contributions of 
each section before and after passing the crystal mid-line can then 
be calculated using the data of Fig. 2.5. If 16 inches from the 
mid-line is chosen as the starting-stopping distance, the total body 
count can be expected to be constant for any longitudinal redistribution, 
A loss of sensitivity, inevitably results. It can be seen that 
commencing and ending at 8 inches, 4 inches and directly below the 
mid-line leads to variations of only0.4^/o, — '1.3°/o and-^4^/0 
respectively. Consequently, for the prototype, the mid-3.ine vras 
chosen as the starting and ending point giving maximum sensitivity.
The variation along the length of the body is then a maximum of 
- 20^/o and, in practice, is unlikely to exceed-7^/o,
-l4 -
TABLE 2.3
ïburce
^osition-
0,51 MeV photopeak. 1.28 MeV phot ope aie.
ots. in 4 mins. /o of maximum ots. in 4 mins.
o . -jo of maximum
leath Xtal centre 401697 100 918 51 ICO
4 inches 281579 70.1 62456 58.0
8 inches 119652 29.8 27738 30.2
.2 inches 33446 8.3 8187 8.9
.6 inches 8205 2.0 2056 2.2
lO inches 2773 0.7 631 0.7
l4 inches 1426 0.4 244 0.3
,8 inches 958 0.2 118 0.1
•2 inches 730 0.2 102 0.1
6 inches
! ! L _ ,
0.1 77 -
1.5 VARIATION OF COUNTING-RATE (A S  PERCENTAGE OF M ID -LIN E  COUNT-RATE] 
WITH LONGITUDINAL DISTANCE
IQp
INTEGRATED 
CONTRIBUTION  
ARBITARY UNITS
DISTANCE
TRAVELLED
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80
8 0 0
u.
24
inchesLO N G ITU D IN A L  DISTANCE FROM CENTRE OF CRYSTAL
FIG 2 .6  INTEGRATED COUNTING - RATES OF PHANTON SCAN - DISTRIBUTED POINT SOURCES
INDWOmL OONmieUTtONS 
BEFORE AND AFTER 
CRYSTAL MID • LINE
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b) Lateral variation:
The results obtained in examining the lateral variation are 
presented in Table 2.4.
TABLE 2.4
Source
Position
0.51 MeV photopeak 
ots. in 4 mins.
1.28 MeV phot ope ole I 
cts. in 4 mins. *
Below xtal centre 99597 22378 1
4- 3 ins. 94061 22086 1
t 6 ins. 78838 18999 j
If symmetry is again assumed, it be calculated that CT (lateral) 
= + 9.7^/0« Part of this variation may be attributable to the small
diameter of the crystal.
c) Vertical or depth variation:
Sources of cobalt-60 and caesium-137 were placed successively 
one inch above the bed to 7 inches above the bed in a water phantom 
eight inches deep. The results obtained are summarised in Table 2.5.
The variation which might be observed in counting a patient in 
the supine and prone positions and summing the results may be simulated 
by suraraing reciprocal results of Table 2.5. The effect of this 
procedure is shoim in Table 2.6. Standard deviations of + 19^/o and 
i 15^/0 are obtained.
d) Redistribution effects in patients:
In studies of iron metabolism (Will, G and Boddy, K., 1966)
(and see Chapter 4), five patients were measured at various times 
up to six hours following oral administration of iron-59. The 
results are repeated in Table 2.7 along with percentage absorption 
at 20 days calculated for each initial result.
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TABLE 2.5
Source Position
60
Co photopeak 
ots, in 4 mins.
Co^^^ photopeak j 
cts, in 4 mins. j
Under 7*‘ water 6108 9453
Under 6'^ water 7191 11451 I
Under 6" water 9678 14752
Under 4" water 12241 19585
Under 3” water 17612 25158
Under 2^  water 22149 34075
Under 1" water 31683 45055
TABLE 2.6
Positions summed Co^^ photopeak 
summed cts..
phot ope ale 
sumrtied cts.
Under 7" and 1'* water 37791 54508
Under 6** and 2" water 29340 45526
Under 5” and 3” water 27290 40910
Under 4" water^x 2« 24482 39170
" 0"= 19.3°/o 14.58°/o
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The maximum variation observed did not exceed t 10 per cent.
This variation produces differences in the final absorption figures 
•which are trivial compared with the normal absorption range of 5.8- 
19.3 per cent.
The redistribution effects in the prototype are slightly greater 
than those described by Warner and Oliver (1966) for a different design 
of shadow shield monitor. These authors describe overall variations of 
t 15^/o for various distributions compared with a point source of the 
same activity in a phantom and for cobalt-58 in patients a maximum 
variation of 3^/o. However, the distance from the crystal face to 
patient mid-line is greater (18 inches) in the latter monitor than in 
the prototype (9 inches), while the prototype is about six times better 
in sensitivity for the same crystal volume and counting-time, \dien using 
the wide energy band technique described by these authors.
2.6 Sensitivity as a function of shield and of crystal volume.
It can be shown (e.g. Watt and Rarasden, 1964} that the 
coefficient of variation C is a minimum with an optimum division of 
total available counting-time T between subject and background and
, b b
0  =  1 ^  +  (EL +  1 ) 2  , _  . _  T ,
“  (D^ D) where B is the joackground counting-
— "'x     f—  rate D is the subject counting-rate
T^ and C = O'
D
Thus, approximately, the percentage standard error (ICOXC) and
the sensitivity, ad defined in section 2.4, are proportional to .
D
If D is constant, as will be the case for a fixed crystal/patient 
geometry and crystal volume, then the standard error and sensitivity 
are directly proportional to tlie square root of the background counting- 
rate. For example, the Stagel shield (13.7 per cent of unshielded
background counting-rate) will be ^13.7/2.2 ~ 2.5 times less sensitive
or have a standard error 2.5 times greater than the final prototype (2.2 
per cent of unshielded background). This simpler design may, therefore,
-16 -
have adequate sensitivity for many clinical applications.
Further, both background and subject counting-rates- are roughly
proportional to the crystal volume (Hiller, ^ 1962) so^that the standard
error and sensitivity are proportional to 3^ and = li. i. e.
D V V%
they are roughly inversely proportional to the square-root of the
crystal volume. Thus, if a total counting time of 100 mins, is
optimally divided between patient and background measurements, the
standard error in measuring 140 gm. of body potassium in the prototype
is about 15 per cent, (from the data of Table 2.2), which is of course
too great for clinical studies. Using an 11-y inches diameter x 4
inches detector instead of the 3 inches diameter x 3 inches currently
used will reduce the standard error to about 3 per cent which is
comparable with that of steel room monitors (Boddy, 1965) and similar
to that obtained in a mobile monitor at Hanford, U.S.A. described
recently by Palmer and Roesch (1965),
2.7 Conclusions:
The prototype has sufficient sensitivity for many clinical 
investigations and is being used for this purpose. On average, 
about 14 patients from hospitals in Glasgow and Greenock are 
examined each week and some of these studies are described later.
It has been shown that, with a detector 11'^  inches x 4 inches, 
sensitivity comparable with steel-room monitors can be expected.
By suitable choice of shield design (as in Fig, 2.2) and of crystal 
volume, sensitivity can be varied according to individual requirements 
and the depth of the pocket.
- 17 *•
CHAPTER III; The Mobile Vn\ole-Bodv Monitor (MEH.B!)^
On the basis of the performance of the prototype, (Boddy, 1965 
and Chapter 2), an application (Boddy, 1954) was made to the Scottish 
Hospital Endowments Research Trust for financial support in construct­
ing a mobile whole-body monitor of high sensitivity. A capital grant 
of £19,745 was awarded by the Trust in May, 1965.
3.1 Special requirements:
Three special requirements for the mobile whole-body monitor 
required consideration, to reduce the weight of shielding and to' 
increase sensitivity. The third requirement was to measure body 
potassium in patients who could not lie flat, such as those suffering 
from osteoporosis or heart complaints.
a) Reduction of shield weight:
The prototype shield weighs approximately 8 tons, while a 
reduction to 7 tons was desirable for incorporation in a mobile 
laboratory on a standard vehicle chassis.
' The prototype shielding studies showed that the final stages 
of the shield contributed comparatively little in reducing the 
background counting-rate. This may be explained by the small 
geometrical probability of a gamma-ray originating in this vicinity 
reaching the detector. Further, if the gamma-ray travelled in a 
straight line to the detector its oblique path length through a 
base or wall of constant thickness would, for geometrical reasons, 
be much greater than that of a gamma-ray passing perpendicularly 
through the base or wall i.e. from directly below the detector.
It may be inferred, therefore, that the limits of the base and 
walls are "over-shielded" compared with the area directly around 
the crystal. Elementary calculations were carried out to ascertain
^ Monitoring Equipment &r Radioactivity at Low-levels IK vivo,
„ 1 « _
the distances and heights of shield at which the centre of the 
crystal could not "see" the surrounding walls or floor or through 
which a gamma-ray lîiust'travel at least six inches. The calculations 
are presented in Appendix 1 and the calculated design is shown in Fig. 
3.1.
, • 
hm Choice of crystal size:
Frcan the discussion of 2.6 it may be anticipated, that a crystal 
volume about twenty-five times greater than that of the 3 inches 
diameter x 3 inches detector of the prototype is required to provide 
sensitivity comparable with steel-room monitors. The choice of 
detection system seemed to be between a single detector ll-g inches 
diameter x 4 inches, the largest detector available at that time at 
reasonable cost, or four crystals 6 inches diameter % 4 inches. The 
advantages of a single crystal (scanning) system over the multiple- 
detector system and the comparative simplicity of shielding have 
already been discussed. A single detector of 11"^  inches diameter 
X 4 inches was consequently selected. Hay and Harinelli (1962) have 
described the advantages of multiple photomultipliers over a single 
large photomultiplier for a crystal of these dimensions and the 
former arrangement was chosen.
c. Monitoring of patients unable to lie flat:
A criticism offered of the prototype was the difficulties 
which would be presented in monitoring patients vho were unable 
to lie flat. In particular, one group of workers wished to measure 
body potassium in patients suffering from heart conditions. As 
potassium is distributed fairly uniformly throughout the body, 
redistribution or geometrical effects are of lesser importance and 
a tilting-chair geometry should be completely satisfactory (Miller, 
1962). The shield could be modified appropriately by mounting the 
central turret on trunnions, allowing it to be rotated, and raising 
a section of the base behind the seated patient. Alternatively, 
when this geometry was required, the turret could be raised by 
jacks or a gantry to an appropriate height and supplementary lead
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side walls added beneath the steel plate. Both arrangements require 
a wall across the monitor on the side opposite to the patient and the 
latter arrangement requires a wall which can be moved into position 
behind the patient. However, the engineering aspects of the latter 
arrangement are simpler to achieve and the weight limitation on the 
mobile laboratory means that in either case the supplementary lead 
must be transported separately. Mock-ups showed that the minimum 
satisfactory clearance from the monitor base to the base plate of 
the turret was approximately 28 inches. With a tilting chair of 
which the back and base are both at 45° to the vertical, the top of 
the patient's head and the eyes are then outmth the steel plate.
The geometrical error involved in this procedure is likely to be 
small and is off-set in practice by the elimination of claustrophobic 
effects which is of particular importance for patients with heart 
conditions.
The depth of the steel plate supporting the turret is 2^ inches 
so that the crystal protrudes by some 13/4 inches below the plate.
The geometry is shown diagrammatically in Fig. 3.2 and in Fig 3.3 
the actual arrangement. A similar geometry is used, for example, 
in the monitors at Los Alamos, Oak Ridge and Vanderbilt University.
Experience showed that to raise the turret while keeping it 
horizontal was extremely tedious, difficult and, with the detector 
in the turret, nerve-racking when three or four separate jacks were 
used. Hydraulic jacks coupled to a ccmmon cylinder were considered 
since a horizontal lift should be more easily attainable. Failure, 
for example, through leakage, could not be ruled out, however, and, 
during the lowering of the turret, simultaneous control of the jacks 
is less adequate. As a lift of 16 inches is required with an initial 
clearance from base to steel plate of only 14 inches, two or three 
stages of lift are required. The cost of the best system was quoted 
as between £250 « £500 as a preliminary estimate. A firm tender was 
not requested! A gantry with pulley, capable of lifting 3 tons and 
tested to 4-g tons, was kindly designed and constructed by members of
- 20 -
Fig. 5.2.
MERLIN TILTING -  CHAIR GEOMETRY
0 * b * 40 4 cm 
c * ZERO
d « 57- 2 cm
<i ■ jS s 45* 
y « 45*
à « ZERO
■Fig. 3o3. MERLIN Chair Geometry 
with Lifting Gantry
the National Engineering Laboratory, East Kilbride. The gantry 
in use is shown in Fig, 3.3 from idiioh it may be seen that the 
structure can be completely assembled and disassembled in the 
mobile laboratory. The lift is inevitably slow and is well 
controlled by the lifting assembly. To maintain the plate and 
turret horizontal presents .no problem and small adjustments of 
the suspended turret are simply achieved whereas with jacks 
such adjustments were virtually impossible.
It was anticipated that a need might arise to make lateral 
scans or to count over individual organs. A tapered slot cut 
across one half of the steel plate supporting the turret could 
accommodate a smaller supplementary detector with a collimator, 
if necessary. The slot would normally be filled with a lead 
block made specifically for this purpose. This facility was 
not difficult to arrange and it seemed worthwhile to incorporate.
3.2 Selection of materials and equipment.
Of necessity, the prototype monitor was'constructed from 
available materials. For MERLIN, on the other hand, some 
selection of materials and equipment could be made bearing in 
mind the limitations of finance and time.
a) The detector:
Tifo tenders were received for the supply of the llg- inches 
diameter x 4 inches sodium iodide detector. Surprisingly, the 
lower tender ©2,600) from Quartz et Silice, Paris, was less than 
half of the higher tender (£5, 8CX)), The specification and 
performance guarantees were identical. At this time, however, 
it appeared that the Quartz et Silice detectors were less widely- 
known than those of their competitors. It, therefore, seemed 
prudent, before accepting this tender, to survey the experience 
of other workers. Information was sought on the ability to 
produce crystals of this size and their performance in terms of
- 2l -
low iivherent backgroimd ( 1 p.p.m. of potassium) and resolution of 
11 o/o or better guaranteed for the Cs-137 photopeak.)
Nuclear-Chicago Corporation (Sheviok, 1965) examined a Quartz 
©t Silice detector II3 inches diameter x g" inch and found this 
extremely well made. Other crystals used for conventional gamma 
ray analysis were also examined and Shevick intimated "they appear 
excellent with regard to resolution and background, certainly as 
good as those made by Harshaif. The University of Helsinki 
(Kantele, 1965) employs an anticoincidence annulus in two "pineapple 
slices" each 12 inches long x 8 inches diameter with a 3 inches 
tunnel; The resolution of this unit is apparently better than 
13 0/0 vhile the best reported in the literature was quoted as 14a2o/o. 
It was also shown by Hill (1965) that, at least, for smaller detectors, 
the resolution of Quarts et Silice detectors compares very favourably 
with that of any of their competitors.
An examination of the background counting-rate of a Quarts and 
Silice 4 inches. diameter x 4 inches detector and a Harshaw 3 inches 
diameter x 5 inches detector was made at Argonne National Laboratory 
(May, 1965). • In the energy range 0.3 - 1.5 HeV, the Quarts and
Silice background was 19 0/0 greater but the crystal volume was 
42 0/0 greater. A detailed exmaination was not made but it would 
seem that the background performances are at least comparable and 
May commented "the basic crystal was certainly as clean as anything 
I've ever seen".
The most detailed comparison has been made by Grinberg and 
Gallic at the Centre d'Etudes Nucléaires de Saclay of the French 
Atomic Energy Commission. Table 3.1 summaries the results 
(Gallic, 1965), and gamma ray spectra obtained are shoivn in Fig,
3.4 Table 3.1.
The measurements were made in the Low Activity Laboratory of 
the Laboratoire do Mesure des Radioelements in a cave of 4 inches of
- 22 -
TiffiLE 3.1
DETECTOR Cs - 137 Resolution 
o/o
Background 
0.1 - 3.2 KoV .
c m
Harshaw - 8” x 4" with unactivated slab 8.6 . 685
Q« and 8# 8" x 4” with unactivated slab 8.6 456 :
Q. and 8. 8” x 4” mthout unactivated 8.5 670
 ^ slab.
TABLE 3.2
Counting
Time
(Mins)
ENERGY RANGE (MeV)
SOURCE 0.11 . 0.41 0.41 - 0.70 0,57 ' 0,70
Counts com. Counts. cm« Couriso  ^ cm.
Virgin Lead 1363.8 201448 147.7 76693 56«24 27066 ' 19,85
\ged Lead 1768.1 265507 150.2 103528 58.55 36275 i 20.52
Background 656.7 140973 215.2 403035 65.53 14833 : 22,59
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leads Three significant conclusions can be drawn* The resolution 
of the large Quartz and Silice detectors is as $ood as those of 
Harshaw and the inherent background seems rather better. Close 
examination of the spectra of Fig. 3=4 suggests that the contaminants 
of the crystals are different, the thorium-232 chain in the former and 
the uranium-238 chain in the latter.
The Quartz and Silice tender was accepted* The crystal assembler 
is shown in Fig- 3,5. Its resolution for caesium-137 is lO^/o.
b) Lead:
The lowest tender for the lead shield and also the most flexible 
arrangement was received from Associated Lead fôl, 730), Lead without 
antimony was specified as it has been suggested (Rondo, 1965) that 
same contamination was attributable to its conclusion. Samples of 
virgin lead and aged lead,- which "would be used for the shield, were 
obtained and monitored in the prototype monitor. An investigation 
of the radioactive contamination of lead (Weller et al-, 1955) showed 
that the principal contaminant was 21.4 - year lead - 210. The energy 
bands chosen were consequently, 110-410 KeV covering the bremnstrahlung 
continuum peaking at about 170 KeV and 410 - 700 KeV covering the most 
prominent structure of the radium daughter spectrum. Fall-out 
caesium-137 was a possible further contaminant and a range of 0.57 - 
0.70 MeV was also examined. Fig. 3.6, shows the spectra obtained 
and the results are summarised in Table 3,2
The specimen slabs were of the same area and thickness and both 
reduced the background counting-rate in each energy range. However, 
the virgin lead was marginally better throughout. The spectra showed no 
differences in structure compared m t h  the background spectrum. Both 
samples appeared free of contaminants and the final choice of virgin 
lead was influenced by knowledge of its source.
The virgin lead (TADMAC - the reverse of CANADA. T) originated
- 23 -
Figo 3o5o Sodium Iodide Detector Assembly 
11g inches diameter x k inches
3-6 SPECTRA OF LEAD SAMPLES
lOOi
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from Trail iu Canada. The geological distribution of uranium- 
bearing ores was described by Van Wambeke, (1965), and it could 
be seen that thé nearest deposits (mainly near Lake Elliot) were 
an appreciable distance from Trail. Uranium ores are of primary 
importance since lead-210 is a member of the uranium-238 series 
while the thorium, and actinium series contain no long-lived 
isotopes of lead.
c) Steel:
It has been reported (for example Spiers (1$62)) that modem 
steels may contain contamination in the nature of cobalt-60^  
occasionally used as a tracer for wear in furnace linings, and 
caesium-137 as a long-lined fission product. Vennart (1965), on 
the other hand, suggests that in Britain the use of cobalt-60 vjas 
limited to only a few foundries as was also the practice of in­
corporating large amounts of scrap, which might be contaminated.
A limited amount of steel was required for MERLIN as a base plate, 
distributing the load evenly on the vehicle chassis, as a supporting 
plate for the turret and also for the lid of the turret. In view 
of the high cost of pre-1945 naval steel and the difficulties of 
obtaining the required differing thicknesses, local steel^ was 
monitored.
Three energy ranges were chosen, 0.60 - 0.72 KeV, 1.1 - 1.4 MeV, 
and 1.36, - 1.56 MeV, corresponding to the photopeaks of oaesium-137, 
cobalt-60 and potassium-40 respectively. Monitoring was carried out 
using the prototype and the results, presented in Table 3.3, show no 
significant effects upon the background counting-rate and no significant 
G ont aminat ion •
d) Formica, etc.
To create the impression of lightness of weight and to 
facilitate cleaning of the monitor, formica was chosen to cover
Samples kindly provided by Col villes Ltd., Glasgow.
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TABLE 3 .3
RESULTS OP MONITORING PLATES OP LOCAL STEEL
— .
Gross Plate (cpra) Background (cpm) Net Plate (cpm)
eel 0.60 1.10 1.56 0.60 1.10 1.56 0.60 1 1.10 1.56
ate -0 .7 2 -1 .4 0 -1 .5 6 - 0.72 -1 .4 0 - 1.56 - 0 . 7 2 1 - 1.40 - 1.56
No- MeV MeV MeV MeV MeV MeV MeV ] MeV MeV
1. 17.8 14.2 8 .5 17.6 14.5 8.9 0.2 M -  ■
2. 15.7 12.6 7.1 15.8 15.7 7.5 - —
1
5. 17.4 13.7 8.0 16.9 15.7 8.8. 0.5 — 1i
4. 18.8 13.7 7.8 18.5 15.9 7.5 0.5 - j 0 .5
5. 16.1 12.7 7 .4 15.8 12.7 7.4 0.5 ;
6« 16.0 13.3 7.5 16.2 11.9 7.7 j , - 1 .4 -
7. 17.8 12.7 ' 7 .2 17.2 15.1 7.2 ! 0 .6 - -
8. 16.8 , 13.3 7 .2 17.2 14.1 7.0 i
i . .......
1
L
0 , 2
the shield. Samples were pre-monitored vdth the results shown in 
Table 3.4. Potassiuiu-40 and caesium-137 seemed the most probable 
of possible contaminants but the differences in counting-rate are 
not statistically significant and no extraordinary peaks were 
observed in the spectrum*
31ie materials of which the bed and chair were to be constructed 
were also monitored and shown to have no significant contamination,
e) Electronic equipment :
The most expensive items of the electronic equipment are 
clearly the multichannel analyser and peripheral units. The large 
number of analysers currently manufactured generally results in a 
marginal preference for one analyser compared with competitive models. 
Following demonstrations of several makes of analyser, however, the 
T.M.C. 404 analyser was selected for its compactness, simplicity of 
manipulation, and its versatility included resolution and integration 
the only analyser at that time with such a facility- The peripheral 
equipment chosen included a built-in H.T. supply, typewriter and tape 
output and tape reader. The H.T. and L.T. supply (Famell) were 
chosen for their stability and low ripple specifications. A mains 
filter unit (recommended by J. Rundo) and a mains stabiliser unit were 
incorporated and a change-over unit was home-built (J. Rowan) to 
avoid switching-off the electronic equipment vjhen changing from the 
generator to a mains supply and vice versa.
The electronic lay-out is sho^ tvn schematically in Fig. 3.7.
f) The Mobile Laboratory:
The principal requirements for the mobile laboratory were as 
follows;
i) Ability to carry at least 7 - 7 ^  tons weight-
ii) Integral chassis to prevent possibility of "jack-knifing”
as could occur with an articulated vehicle 6n, for example,
icy roads.
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TABLE 3.4
Examination of Foimica
Energy Formica + Bgd. Net
Range Bgd.
toeV) cpm. cpm.
cjpin. ■
0.6 - 0.72 14.8 14.6 0.2
1.36-1.56 7.30 7.23 0.07
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iii) Laboratory length of approximately 24'^  feet vzith recessed 
instrument compartment behind the driverLs cab, 
iv) Generator to provide electricity, making" the laboratory self- 
contained,
v) Heating and air conditioning unit, with theimostatio control, 
to provide temperature stability and improve gain stability of 
the electronic equipment as well as ensuring patient comfort»
The tender from S,K,T,, G1 asgow best met these requirements.
The interior of the vehicle and the scanning-bed geometry are 
shown in Fig 3,8,
3,3 Shielding studies with 5’’ x 5” and 3" x 3" detectors;
To allow the shielding studies to proceed before delivery of 
the 11^ ' inches diameter x 4 inches detector. Quarts and Silice 
kindly loaned a 5 inches diameter x 5 inches detector. Additionally, 
the 3 inches diameter x 3 inches detector selected for cotmting over 
specific organs was delivered promptly. The 5" x 5“ detector was 
used throughout because o-f its larger volume but measurements were 
also made with the 3" x 3'* detector for comparison.
The shield was built up in the stages indicated in Fig 3,1, 
Background measurements were made at each stage vdth the detector 
at the height calculated in Appendix 1, (1.22 inches above lower 
face of the base plate, the "high" position, and with the crystal 
face level with the lower fade of'the base plate (the "low position"). 
The results are summarised in Table 3,5 and Table 3.6,'
With the complete shield, the low position background is about 
3 - 10 o/o greater than in the high position for the high energy 
range. The high position is about 20 o/o lower in the lovrer energy 
ranges. The 2 inch stages are more effective with the crystal in 
the low position, as might be expected, but the back ground reductions 
compared with the previous stages are small, confirming the findings
" 26 — «
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Figo 3o8o MERLIN - Scanning-bed Geometry
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with the prototype. The baokground counting-rate with the calculated 
shield was less than 2^/o of the unshielded background.
The shield was modified empirically, bearing in mind the requirements 
of the tilting-chair geometry, to detenaine if the background counting- 
rate could be further reduced. The results are shovm in Table 3.7.
Using the bricks which comprised the 2 inches thick walls and base, 
the walls supporting the turret were increased to 8 inches and the 
height of the remaining walls were increased by about 6 inches in a 
configuration more suitable for the tilting-chair geometry (shield 
condition 2), The overall background was reduced by about 10°/o 
compared with that of the calculated shield.
Cadmium has been used as the lining of lead rooms (Ï.A.E.A.,
1964) largely to absorb lead X-rays of about 75 KeV. A shield of 
cadmium, 0.5 lams. thickness, was placed around the detector (shield 
condition 3) and produced no statistically significant difference in 
any of the energy ranges of Table 3.7. The energy range 0.05 - 0.15 
MeV was also examined and no significant reduction could be established.
The effects of an inert water phantom are shovjn in shield condition
4. In the lowest energy range, the background was increased by about 
7°/o and reduced by roughly the same amount in' the higher energy ranges. 
These changes are of similar magnitude to those described by Rondo,
(1962), Vennart, (1962) and Burch (1962), and smaller than those 
observed by Lidan, (1962).
To investigate the effect of additional lead close to the crystal 
without increasing the shield weight, the bricks comprising the last 
layer of the 8 inches wall were removed. One layer, 4 inches high 
and 2 inches thickness, was then placed close to the detector inside 
the turret. As may be seen in shield condition 5, the backgrounds 
are then about 15°/o less than those of the calculated shield.
Three layers high were then constructed, further reducing the background 
by about 7°/o on average.
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The shield configuration of condition 6 seemed to produce lower 
background counting-rates while being quite suitable for the tilting- 
chair geometry.
3.4 Shielding studies with the 11"^  inches x 4 inches detector.
The shielding studies with the 5 inches diameter by 5 inches 
detector were repeated with the Ils inches x 4 inches detector as 
far as the complete calculated shield. Tiie modified shield was 
then constructed. There were two reasons for this procedure, 
firstly the difficulties of extrapolation from crystals of snioller 
volume and face area and, secondly, it is of possible interest to 
be able to estimate the sensitivities idaich can be achieved at the 
various stages of the shield construction. The results of the 
background measurements, with the crystal in the high and low 
positions, are presented in Tables 3.8 and 3.9 respectively.
Comparison of the present results with those obtained using 
the 5 inches diameter x 5 inches detector shows that the initial 
shielding stages are less effective with the larger detector.
This may be explained by the larger surface area and face area of 
this detector, whose diameter is almost half the length of the 
6 inches thick base directly beneath the detector. The complete 
calculated shield, however, appears to be equally effective and the 
background reductions are similar to those obtained by Killer, (1958), 
and Kay and Karinelli (1962), (see section 2.2) via. 1 - 2°/o«
The modified shield was marginally better than the calculated 
shield but the improvement was loss than with the 5 inches x 5 inches 
detector- In view of its additional advantages for the tilting-chair 
geometry, the modified shield design was adopted. It is shovm in Fig, 
3.8 and diagrammatically in Fig. 3,9
3.5 Comparison of background counting-rate m t h  other monitors in 
Britain.
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To put the effectiveness of "the shield of MEHLIN into 
perspective^ a comparison has been made of the background counting- 
rate per unit crystal volume (High position) with whole-body monitors 
in Britain using* the data of the I»A«E«A« Directory of VJhole-Body 
Radioactivity Monitors (1964) or of a comparison conducted by Glass 
(1965). Table 3»10 summarises the results for the higher energy 
range and Table 3.11 those for the lower energy range.
In the higher energy range, it can be seen that the Background 
Index for MERL3H is smaller, and therefore better, than those of the 
steel-room monitors of the U.K.A.E.A. and Addenbrooke *s Hospital, 
Cambridge and those of the monitors at Sutton and the Radcliffe 
Infirmary, Oxford. It would appear to be similar to the Background 
Indices of the Harwell lead room and the steel-room monitor' at the 
University of Birmingham. The Monitor at the General Infirmary, Leeds, 
is significantly better than KEÏ3L.ÏE \d.th respect to the background 
counting-fate. Direct comparison, however, is slightly misleading.
The Leeds monitor is situated in a basement with a 30" slab of concrete 
and a four-storey concrete building above it equivalent to at least 5 ft, 
of concrete shielding. A difficulty in making such intercomparisons 
in terms of counting-rate/unit volume, is thus illustrated and this 
criticism applies equally to the cases favourable to MERLIN. It was 
for this reason that the MERLIN shield performance at each stage was 
described as the percentage reduction of background counting-rate, 
v^ich has more significance regardless of the initial unshielded 
c cunt ing - rat e.
Table 3oil shows that, even in the lower energy range where 
scattered radiation may be significant in an open system such as 
MERLIN, its performance relative to the other monitors is generally 
not worsened^ The ratio Monitor Background Index/MERLIN Background 
Index is actually greater for the lower energy region than the higher 
energy region for all monitors but the Leeds monitor and, possibly, 
the Harwell monitor in the range 0.27 - 0.45 MeV.
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TABLE 3.10
Comparison o f Baokgcp-und Indices (cpm/cc) in  Higher Ener,gy Regùon
Monitor lo ca tio n Energy range 
MeV
Monitor Background 
Index ^2 
(cpm/cc) X lO"
MERLIN Background 
Index 
(cpm/00) X lO"
> Sutton 1,37 -  1.55
' ■ — ............. 'f------  —
4.99 I 1.52
, Windscale 1.295 -  1.625
— T  ------ - ■ ------
2.99 ! 2.48
» W in fr ith 1.28 *- 1.78 5.71 j 5.21
g
, Bounreay 1.27 -  1.65 4.66 1 2.75
o f Birmingham 1.27 -  1.61 2.60 i 2.58 i;
T
B* Harwell  ^ m u ltip le  
single
1 .0  -  1 .4 5.55 i 5.55 Î 
5.79 1
S>rooke*s Hosp. Cambridge * 0.95 -  1 .4 5.05 1 5.87
.ffe  In f#  Oxford^* 
Marsden Hosp. Sutton
0 .4  -  1 .5 28.0 1 17.0 i
76.5 !
i l  In f .  Leeds 0 .1  -  2 .0 15.9 j 58.0
Enclosure key: 0 « Underground chalk
C* Chalk in  hags
Xi« Lead room
L* Lead shadow-shield
S. S teel room.
TABLE 3.11
Ccmparison of Background Indices (cpm/cc) in Lower Energy Region
nitor
cation
Energy range 
MeV
Monitor Background 
Index 
(cpm/cc) X 10
MERLIN Background 
Index 
(cpm/cc) X 10
»Sm Sutton ^ 0.6 - 0.73 18.0 2.68
•E. Winfrith^ ^ 
eral Inf., Leeds
0.58 - 0.81 6,36
3,13
4.16
.E. Windscale^ 0.52 - 0.80 7,88 5,77 !
S7. of Birmingham 0.44 - 0.58 5.28 4,91 :
.R.E, Harvrell- multiple
single,. ^  
il Marsden Hosp, Sutton
0.32 - 0.4
3,48
2,94
15.7
3.22 j
inbrooke * ^  Hosp, Cambridge 
irai Inf. Leeds. . ■ '
0.27 = 0.45 12.9 
, 2.0
7,25 ;
iliffe Inf.^ Oxford 
il Harsden Hosp. Sutton
0.17 - 0.44 32.9
59.9
12.9
!
Enclosure Key: C Underground chalk 
cF Chalk in bags 
L Lead room
gg
L Lead shadow-shield 
S Steel Rocan
HERLÏH’s favourable perfoiiaance compared with, for example, the 
steel-roora monitors may be surprising at the first impression, 
particularly in view of the much smaller shield weight. It must be 
realised, however, that the 30 - 50 tons of 5 inches thick steel 
room represents no better shield than if this thickness of steel 
was limited to and completely surrounded the detector(s) only. The 
4 - 6  inches of lead used in MERLIN is, therefore, equivalent to a 
complete room of these thicknesses except that the system is "open" 
and may be susceptible to scattered radiation.
However, the detector(s) inside the steel or lead room are 
also susceptible to scattered radiation since a gamma ray having 
entered the room may have equal difficulty in leaving itj
This may be illustrated by the reduction in residual background 
in the steel/lead room at Leeds when a close-fitting lead shield was 
placed around the detectors (Wilson, 1964), The scattering area 
and volume of heavy elements is less with the shadow shield and only 
the crystal face area is "exposed" while a close shield on the crystal 
walls might be considered'unnecessary inside a steel room. The effects 
of atmospheric radon, thoron and their daughter products and the 
variation in their concentration may similarly be reduced because 
of the proximal shielding, the smaller exposed area of the detector 
and the smaller volume of air between the detector and shield.
3,6 Redistribution effects in scanning bed geometry:
The variation of counting-rate with distribution of the isotope 
in the body was again investigated using point sources and water phantoms 
and also patients (see section 2.5).
a) Longitudinal variation;
The results for the OaSl MeV and 1.28 HeV photopeaks of a 
sodium-22 source, placed centrally and consecutively at points six inches 
apart along the longitudinal axis, are summarised in Table 3.12 for the 
crystal in the high position.
The results for the crystal in the low position are presented
TABLE 3.12
Table 3.12 for the crystal in the high position.
JRCE
3ITI0N
0,51 MeV photopeak In28 MeV phptopealc i
cts in 4 mins o/o of maximum cts in 4 mins o/o of maximum \
ith xtal centre 632800 100 202300 100 (!
.nches 505000 80 166000 82 I
i
inches 230000 36 81500 40
inches 72800 11 27000 13
inches 24000 3.8 8200 4 B 1
inches 8800 1.4 1700 1.4
inches 3800 0.6 900 0.5
in Table 3,13.
Tables 3,12 and 3ol3 show that the longitudinal variation is very 
similar for both crystal positions and photopeak energies. Mean values 
are plotted against source position in Fig. 3.10. Symmetry is assumed. 
Tl\e results of graphical integration over given distances of travel are 
presented on the same figure. Assuming again the source distribution 
of section 2*5, the integrated contribution of each section before and 
after passing the crystal raid-line has been calculated for various 
positions of starting and stopping counting. The results are shovna 
in Fig. 3.11.
Fig* 3.10 shows that the counting-rate falls to lO^/o of the 
maximum value at about 20 inches from the crystal mid-line and is 
virtually confined to 32 inches on either side of the crystal mid­
line. The counting region is about twice the size of that found 
with the 3 inches x 3 inches detector in the prototype monitor. 
Sensitivity will be improved consequently while redistribution effects 
are marginally worsened. Fig* 3,11 shows that commencing and ending 
the scan. 12, 8 and 4 inches at each side of the crystal centre line 
and directly beneath the crystal centre would produce variations of 
0.8^/o, 1.9^/Of 4g2^/o and 8e4^/o respectively.
The extreme opposite of this case is that in which the total 
activity is concentrated at one point, and the worst geometrical 
position is clearly if the activity is four inches from either 
extremity of the body* In this case, with the scan again coramenaing 
and ending 12, 8 and 4 inches at each side of the crystal centre­
line and directly beneath the crystal centre, the retention, compared 
with that when the source is centrally positioned as wiien in the 
intestine follomng an oral dose, is underestimated by 100(1-2700/
2800) °/o = 3.5°/o, 100 (1 - 2560/2800) = 8 °/o 100(1-2300/2300) = 
18°/o and 100(1-1900/2800)= 32°/oo Such an extreme case is unlikely 
to arise in practice; the concentration of iodine in the thyroid 
gland may be the closest approximation, when the source is, largely,
— 31 —
TABLE 3.13
RGE
ITIŒ
0.51 MeV photopeak 1*28 MeV photopeak 1
cts in 4 mine o/o of maximum cts in 4 mins o/o of maximum
ath xtal centre 850000 100 300000 100 1
inches 640000 75 232000 76 ;
inches 300000 35 111000 37 j
Î
inches 114000 13 45500
I
15 ■
i
inches 48000 5.7 19000 6*3
inches i 23400
1
2.8 9100 3«0
inches 13000
5
1.5 4900 1«6
:|G 3. lO VARIATION OF COUNTING-RATE (AS PERCENTAGE OF MID-LINE COUNT-RATE) 
WITH LONGITUDINAL DISTANCE
lOO
DISTANCE
TRAVELLED
INTEGRATED 
CONTRIBUTION 
ARBITARY UNITS
0  — 4" 468
4 8" 403
8” ~ 12" 265
12" 16“ 131
16" 20" 63
20" — ♦ 24" 32
24" 32" 21
o  ~ 32" — 1403
24 16 8
LONGITUDINAL DISTANCE
O 6 16 24
FROM CENTRE OF CRYSTAL " Inches
I l l  INTEGRATED COUNTING -  RATES OF PHANTOM SCAN - DISTRIBUTED POINT SOURCES
CRYSTAL
MID
LINE
12" 16" 20" 24" 26" 32" 36" 40" 44" 46" 52" 56" 6o" 64" 66"
<j) 4|6 6|?l tl|6 12^67 13^50 13^82 iy>3 1^3 I4j33 1^3 1^3 1^ )3 iy>3 I4p3 I4j]g <j)
O 1403 (403 1403 1403 (403 (403 (403 (403 1403 1403 (382 1350 1267 1156 691 486 O
CRYSTAL
I4ID
M l
I iwp 1 9  Dj67 13,50 (362 m 3  1^3 (403 (^3 1^3 (403 (433 ( ^  1433 ( ^  1403 O
♦ } f 1---1---1---1---1---1---h--1---1---1---1---1---1---1---1---1
O 1403 1403 M03 1403 1403 1403 (403 1403 1403 (403 1403 1382 1350 1287 1156 891 O
CRYSTAL
MID
UNE
t— el_^
t y U56 12^67 13^ (3^2 I4p3 I4j33 I4p3 I4j33 I4p3 (403 (4j33 (403 1403 I4p3 (403 1403 (j)
O li)3 1403 1403 1405 1403 1403 1403 (403 1403 1403 1403 (403 1382 1350 1287 1156 O
about twelve inches from the top of the head. 'The corresponding 
maximmu underestimates would then be 0/7, 1 = 7, 3«5 and 8°/o
respectively if all of the iodine was in the gland, compared with
the nonaal fraction of 0=2 I960). It may be implied,
therefore, that the probable distribution of a given isotope should
be considered in order to determine at what position a scan should 
commence and finish. In general, however, the error involved in 
taking the crystal centre-line as the start-stop point is unlikely 
to exceed'^ 1-2^/Oa
The micro-switch system devised for HEELIM allovTS counting to 
start and stop at any distance within 18 inches on either side of 
the crystal centre-line. At 18 inches start-stop, the longitudinal 
variation is unlikely to exceed^'^lo8^/o in the most extreme case.
This flexibility is achieved simply by fixing two microswitches, 
one at each side of the crystal centre-line and at 18 inches from 
the centre-line. The switches are placed on the base outside the 
rail on the opposite side from the driving screw. They are off-set 
transversely so that each switch is operated by only its ov?n actuator. 
The actuators are adjustable each with a pointer to a steel-tape 
measure fixed to the bed and they may be firmly located by a screwed 
clamp over the side of the bed» With the actuator-pointers set at 
the head of the bed and at the patientas height, counting begins and 
ends 18 inches before and after the crystal respectively. The scan 
is begun and ended beneath the crystal centre-line by setting the 
actuator pointers at 18 inches from the head of the bed at the 
patientas height minus 18 inches.
None of the monitors using the scanning technique and listed 
in the I.A.E.A. Directory of hhole-Body Radioactivity Konitors, 1966, 
(Tables XIII and XIV) are as flexible as MERLIM in this respect.
Only two would appear to have adjustment of either the distance 
from the shoulder at which the scan commences or the overall length 
of the scan. Furthermore, the total scan length in MERLIN can exceed 
275 cms whereas the maximum scan length of the single detector monitors
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is 235 cms. (I.A.E.A, monitor, Vienna) arid of the two-detector monitors 
is 175 cms. (University of Lund, Sweden).
Cf the monitors using the multi-detector stretcher technique 
listed in Tables X and XI (loc« cit.) none would appear to use the 
detectors outside the extreme lengths of the body. It would also 
be more difficult and cumbersome to adjust the detectors compared 
with the simplicity of adjusting the micro-switch actuators in 
MERLIN,
b) Lateral Variation»
The lateral variation was investigated with a sodium-22 source 
placed on the phantom mid-line directly below the crystal centre, 
and displaced horizontally across the monitor at 3 inches and 6 inches 
on either side of the central position. High and low crystal positions 
were investigated. The results for the 1*28 HeV photopeak are 
summarised in Table 3.14* Counts are corrected for backgrourtd* .
The standard deviations for these data ar e 6 . 7 o / o for the high 
position and"^9*8o/o for the low position* These estimates are 
pessimistic as they represent the differences obtained with point 
sources at discrete distances* In the high crystal position, a 
point source at the ’bentre’* of the patient and."redistributed" 
becoming a point source sixf inches off the mid-line would be under­
estimated by about 15o/o* Similarly, for the low crystal position^ 
the unde rest iraate would be about 20 o/o*
Tne extremity of those latter estimates requires emphasis*
Tlio source used and the positional limits were not representative 
of conditions likely to arise in practice* Complete transfer of 
an isotope from the gut to the kidneys or spleen is probably the 
closest approximation, but such a situation is highly improbable.
The kidneys usually lie closer to 3 inches on either side of the body 
mid-line than the 6 inches assumed in the extreme case of the phantom* 
At 3 inches, the underestimates would be about 3o/o and 5 o/o for the 
high and low positions respectively*
TABLE 3.14
Source
05ition from centre
Crystal Position. ;
HIGH LOT
Cpm
o/o
Centre Cpm '
o/o
Centre
6 inches 172,800 1 85 . 230, 900 79
3 inches 196,400 97 271,100 : 93 I
antre 202, 200 100 292,400 ! 100 ;
3 inches 196,200 97 1 273,800 94 .
6 inches 173,200 1 85
1
I 231,200 79
The standard deviation is smaller with the larger crystal than 
with the 3 inches x 3 inches detector of the prototype at the same 
patient"detector distance» It seems likely, therefore, that the 
lateral variation will be less in monitors using a single large 
detector or with two or more crystals across the body» No monitor 
listed in the I.A.E.A* Directory of Whole-Body Radioactivity Monitors 
(1964) utilises a detector of this diameter in scanning«bed or multiple- 
detector stretcher geometries* However, the Hanford Mobile Monitor 
uses an 11"^  inches x 4 inches detector (Brady, 1964 Private 
communication), and the latest monitor at Leeds is particularly 
flexible since, v/hen completed, it will be possible to use the 
scanning-bed geometry with 2 crystals, each 6 inches x 4 inches, 
across the body as well as in a multi-detector stretcher geometry.
c) Depth variation:
In view of the similarity between the depth variations observed 
for caesium-137 and cobalt«60 with the prototype, (Section 2-5), this 
investigation was limited to cobalt-60» Measurements were made, 
however, in the photopeak region and also using a wide energy band 
of 0.4 - 1.4 MeV.
The source was placed one inch above the bed beneath 7 inches 
of water and lifted one inch successively until it was beneath only 
one inch of water, representing variation over the depth of the body 
to one inch below either surface. The results are presented in 
Table 3ol5.
These counting-rates may represent those in a patient measured 
in either the supine or prone positions» The standard error is 
that which might be obtained if the depth of the source varied in 
a regular manner in successive measureraents* Such a situation may 
be unrealistic but, at worst, a basis for comparison is provided 
shovri-ug, as might be anticipated from experience with the prototype 
monitor, that the crystal high and using the wide band counting 
technique (Warner and Oliver, 1966) reduces the standard error»
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TABLE 3.15
cpm. in wide energy band ■ cpm in photopeak
ource 
osition Crystal high j Crystal Low Crystal High Crystal Low j
er 7" water 44411 49509 21651
1
27887 !)
er 6" water 54491 63085 27036 36071 1
er 5" water 66294 81100 34071 46549 j
er 4" water 81825 105165 43459 61449 I
er 3" water 101295 134207 55945 81058 1
er 2" water 126695 173748 73112 108737
er 1" water 153734 218422 94024 141970
1 44.3o/o 52«2o/o 52.5o/o 57.7o/o
The error is, nevertheless, appreciable»
The counting-rates equivalent to measuring a patient in the 
supine and prone positions may be obtained by summing results^ 
under 7" water 4- under 1" water, under 6" water 4 under 2" water, 
etc* The corresponding^values are shoVTii in Table 3*16» ' The 
standard errors are reduced by factors of 4 - 5«
With the detector raised to the maximura height, (crystal 
face to patient mid-line = 29b8 eras), the depth variation was 
again investigated with the results given in Table 3»17» The 
standard errors are further reduced» The lateral variations 
were very similar to those with the crystal in the high position»
The worst case, counting supine and prone, is ‘approached by 
'assuming a source close to the centre line moves entirely to the 
surface of the body» Overestimates of 27^/o, 21^/o and 17^jo
might result with wide band counting with the crystal in the low, 
high and maximim positions respectively» The results, however, 
are for a point source at these depths whereas in reality all 
sources within the body are of finite depth and would "overlap" 
successive positions of the point source* For exemplè, if 
initially the source within the body overlapped the "under 4" 
water positions 4- "under 3" and 5" water" the aggregate counting- 
rate represents thè mid-lihe value* Thè sum of "under 1" and 7" 
water" 4- "under 2" and 6" water" approximates to the counting-rate 
at thè surface of^the body* The corresponding over-estimates are 
reduced to approximately 18»5^/o, 14»5^'/o and ll^/o.
d) Variation of the initial counting-rate in patients:
In a study of the effects of various proprietary pharmaceutical 
on the absorption of iron, (Boddy and Will, 1967), tablets of iron-59 
ascorbate were administered to normal and anaemic subjects» Several 
patients were measured imraediately after taking the tablet and 
successively at intervals of about one hour during the working day» 
Measurements were made with the detector in the low position and at
TABLE 5.16
summed cpm* - wide "band
Positions summed f
Crystal high Crystal low
summed cpm* « photopeak
Crystal high Crystal low
der 1" + 7" water 
der 2" + 6*' water 
der 5*’ + 5" water 
der 4" + 4" water
C  ”
198145
181186
167589
165650
9.2#
267931
236833
215307
210330
11.3#
115675
100198
90016
869I 8
13.1#
169857
1448O8
127607
122898
14.8%
TABLE 3»17
>urce cpruo max. ht,
)sition
Wide band photopeak
1er 7" water 37042 18034
1er 6" water 44751 22227
1er 5" water 54469 27793
1er 4" water 66923 35411
.er 3" water 80602 44117
.er 2" water 98879 56405
.er 1" water 119425 72429
0 41.6 o/o 49.6 o/o
Positions
summed
summed cpxi,
Wide band ’ photopeak
Under 1" 4 *  7" water !
Under 2 "  4 - 6 "  water i
i
Under 3" t 5" water j 
Under 4" 4-4" water I
156467
143640
135071
133846
90453
78632
71910
70822
0 7.3 o/o ; 11*5 o/c
t h e  ma:<iiaui‘a h e i g h t »  T y p i c a l  r e s u l t s  a r e  p r e s e n t e d  i n  Talsle 3 * 1 8 »
T h e  s t a n d a r d  e r r o r  i s  l o w e r  u s i n g  t h e  w i d e  b a n d  c o u n t i n g  t e c h n i q u e  
c o m p a r e d  w i t h  m e a s u r i n g  o n l y  o v e r  t h e  p h o t o p e a i c  a n d  l o w e r  w i t h  t h e  
d e t e c t o r  a t  t h e  m a d m u m  h e i g h t  » T h e s e  f i n d i n g s  a r c  i n  g o o d  a g r e e ­
m e n t  w i t h  t h e  p h a n t o m  s t u d i e s *  O v e r a l l  v a r i a t i o n s ,  d e f i n e d  a s  
I C O  ( H i g h e s t  c o u r t - r a t e / L o w e s t  c o u n t - r a t e  -1 ) ,  a r e  12, I C o / o  a n d  
9 o / o ,  7 . 5  o / o  r e s p e c t i v e l y *
3 b 7 C o m p a r i s o n  w i t h  r e d i s t r i b u t i o n  e f f e c t s  i n  o t h e r  m o n i t o r s :
I t  i s  p e r h a p s  p e r t i n e n t  t o  a s k ,  i n  a s s e s s i n g  t h e  p e r f o r m a n c e  
o f  t h i s  n e w  d e s i g n  o f  m o n i t o r ,  w h e t h e r  d e p t h  v a r i a t i o n s  o f  t h i s  
m a g n i t u d e  a r e  l i k e l y  t o  b e  g r e a t e r  o r  s m a l l e r  t h a n  w i t h  o t h e r  w h o l e -  
b o d y  m o n i t o r s .  p r i n c i p a l  f a c t o r  i s  c l e a r l y  t h e  p a t  l e n t - c r y s t a l  '
d i s t a n c e »  I n  t h e  m a x i m u m  p o s i t i o n ,  t h i s  d i s t a n c e  f r o m  c r y s t a l  f a c e  
p a t i e n t  m i d - l i n e  i s  2 9 c 8  eras* a n d  i n  t h e  h i g h  p o s i t i o n  i s  2 5 » 4  c m s  » 
a n d  l o w  p o s i t i o n  2 0 . 3  c m s  * T h e  I » A , L . A *  D i r e c t o r y  i n d i c a t e s  t h a t  
m o n i t o r s  u s i n g  s c a n n i n g - b e d  t e c h n i q u e s  a n d  a  s i n g l e  d e t e c t o r  u s e  
s i m i l a r  d i s t a n c e s  i d a i l s t  t h e  t w o - d e t e c t o r  s c a n n i n g  m o n i t o r s  a t  L u n d ,  
S w e d e n ,  o p e r a t e  w i t h  o n e  d e t e c t o r  4 5  eras» a b o v e  t h e  b e d  b u t  w i t h  
t h e  o t h e r  o n l y  2 5  c m s .  b e n e a t h  t h e  b e d *  O n  t h e  o t h e r  h a n d ,  m o s t  
m o n i t o r s  u s i n g  t h e  m u l t i - d e t e c t o r  s t r e t c h e r  t e c h n i c a l  e s  o p e r a t e  a t  
d i s t a n c e s  s m a l l e r  t h a n  t h o s e  i n  M E R L I N ,  p a r t i c u l a r l y  i n  t h e  c a s e  o f  
d e t e c t o r s  b e n e a t h  t h e  b e d .
T h e  t i l t i n g - c h a i r  g e o m e t r y  i s  a l m o s t  i n e v i t a b l y  w o r s e  t h a n  m o s t  
o t h e r  g e o m e t r i e s »  O v e r  t h e  f i r s t  f e w  h o u r s  a f t e r  a d m i n i s t r a t i o n  o f  
i r o n - 5 9 ,  P r i c e  e t  a l .  ( 1 9 6 2 )  o b t a i n e d  v a r i a t i o n s  i n  t h e  c o u n t i n g - r a t e  
b e t w e e n  0  a n d  2 0  o / o .  h a v e r s t e n  ( 1 9 6 4 )  h a s  s h o v m  t h a t  v a r i a t i o n s  i n  
r e s p o n s e  o f  0 * 8  t o  2 . 0  f o r  t h e  s o m e  a c t i v i t y  i n  d i f f e r e n t  ^ o r g a n s ’ o f  
a  p h a n t o m  ar^d u s i n g  a  t i l t i n g - c h a i r  g e o m e t r y  w e r e  r e d u c e d  t o  0 * 9 5  
t o  1 » 1 5  u s i n g  a  s c a n n i n g - b e d  g e o m e t r y .  I t  m a y  b e  i n f e r r e d  t h a t  t h e  
t i l t i n g - c h a i r  g e o m e t r y  w i l l  b e  m o s t  u s e f u l  f o r  i s o t o p e s  w h i c h  a r e  
d i s t r i b u t e d  f i a r l y  u n i f o r m l y  t h r o u g h o u t  t h e  b o d y  a t  l o w - l e v o l s  o f  
a c t i v i t y  s u c h  a s  i n  m e a s u r i n g  b o d y  p o t a s s i u m »  F o r  o t h e r  i s o t o p e s  
t h e  i m p r o v e m e n t  i n  s e n s i t i v i t y  m a y  b e  o f f - s e t  b y  t h e  g e o m e t r i c a l  
e r r o r s .  C o n s e q u e n t l y ,  M E R L X L ^ s  t i l t i n g - c h a i r  g e o m e t r y  w i l l
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TABLE 3 a 18
)etoctor in low position. Detector at maximum height
IRetention (Supine and Prone) i Ret ent i on (Sud ine and Prone)
1 Narrow Band Wide Band Time Harrow Band Wide Band
1 □pro 1 o/o cpm , j o/o Hrs- cpm ; o/o cpm , o/c
21,816 100 57, 073 100 0 13,029 100 28, 554 i ICO
26,482 98.7 55,758 97.7 1 12,647 97.1 28,124 i 93*5
26,969 100.6 55, 709 97.6 2 13, 506 103.7 29,446 : 105cl
27, 918 104.1 58, 220 102.0 3 13,811 106.0 30,249 :105*9
26,545 98.9 55,055 98.2 4 13,795 105.9 '29,873 !lDi.S
25,880 96.5 54,802 96.0 1 5^ 13,707 105.2 29,577 :103.5
24,936 92.9 53, Oil 92.9 ; IS,648 104.7 '29, 569 '103.5
: 858 3.24 1, 527 2.74 ■ O'- .411 1 3.1 690 ' 2.35
largely be confined to measurement of potassium-40 in patients who 
are unable to lie flat.
In a oanparison of the perfoimance of seme whole-body monitors 
in Britain, Glass (1965) showed that the depth variation using a 1*75 
metre arc geometry was surprisingly large. Sources were placed on 
the top of the phantom and then below the phantom, which is more 
pessimistic than the measurements in MERLIN. Using the wide energy 
range for iron-59, the top position over-estimated by about 23^/o 
compared with the sources uniformly distributed and the bottom position 
underestimated by about 36^/o. Counting prone and supine would 
apparently reduce the error to about 6.4^/o compared wdth 11^/o in 
MERLIN, Sensitivity with the arc, however, is comparatively poor*
Warner and Oliver (1966) have described a shadow-shield monitor 
in which shielding is confined to two detectors 18 inches on each 
side of a motorised bed. Collimation is also used to reduce re­
distribution effects. Sensitivity is sacrified since the prototype 
with only a quarter of the crystal volume is about three times more 
sensitive. The redistribution performance, however, is reiaarkably 
good. The depth variation compared with a small central source was 
quoted as not exceeding -6^/o to t lO^/o which would be equivalent to 
an overall variation of about 12^/o, The corresponding variation for 
MERLIN with the detector at the maximum height is about 17^/o. In two 
patients on whom successive measurements were made without faecal loss 
between measurements, Warner and Oliver observed a m.aximura variation* of 
only about 3^/o compared with overal variations of about 7 - 12^/o in 
MERLIN. The better performance of the former monitor with respect to 
redistribution is understandable in view of the greater crystal-patlent 
mid-line and the findings described in section 3,6c. On the other har.d, 
the sensitivities of this monitor, as mentioned earlier, is very much 
less than HERLHh or the prototype monitor. Naversten (1964), using a 
scanning-bed monitor of high sensitivity with detectors above and below 
the bed and 70 cm. apart, observed overall variations in phantom studies
- 37 -
of up to 21^/o MERLINperformance compares not unfavourably, 
therefore.
3.8 Performance of MERLIN and a comparison with some other Monitors 
in Britain:
The counting-rates per unit activity have been measured in MERuH'I 
for cobalt-58 and iron-59 in patients to whom these isotopes had been 
administered. A polythene phantom containing 140 giu of potassium 
in water was also monitored. The results are summarised in Table 
3.19.
*
Data for potassium-40 measurements in other monitors in Britain 
are included in the I.A.E.A. Directory of Whole-Body Monitors (1964) o 
Using the equation described in section 2.6 and assuming a total body 
content of 140 gm. of potassium and a total counting time (background 
time and subject time) of 100 mins., these data have compared with 
those of MERLIN in Table 3.20.
The scanning-bed geometry is, apparently, several times more 
sensitive than the chalk room monitors and virtually identical in 
sensitivity with the steel room monitors. The tilting-chair georaetry 
is more sensitive,
A comparison in terms of cost shows a startling contrast. As an 
installed monitor, MERLjIN could be established for about £6, 500 including 
the shield (£1,700), an ll"^  inches x 4 inches detector £2,6.00), 100- 
channel analyser ivlth printer and H.T. supply (about £2,000) „ The steel 
room of a commercial monitor costs from about £5,500 to £9,000 and the 
complete system frccii £20,000 - £30,000 excluding transport and erection 
costs and the cost of a special building if this is required to house 
the monitor.
- 38 -
TABLE 3b19
Isotope Energy range 
MeV
----  --P
cpm/uc Background
cpm
1« Detectoï at maximum, height: 
1.36 - 1.56
■
, 0,66 I 126
i1
!!
Fe-59 0.4 — 1.38 14,800 I 1065
1.0 - 1.38 6,900 !f ' 238 }
Go-58 0.3 — 1.0 23,000 1 1104
1
j
1 0.74 « 0.89 8,500 i 153 11
:
2m Deteotqr in low position: 1
K-40™ ; 1.36 - 1*56 î 0.82 137 1
Fe-59 ! 0u4 — lu38 : 27, 900 1150
i
]
1 1.0 - 1.38 ; 13, 300 260
!
1
3« Tilting-chair geometry:
K-4cF i 1.86 _ 1,56
i_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ■
' 1.17
------ --- — 1
133 j
% cpm/girtR,
TllBLE 3.20
Monitor
Location
Background
cpm
cpm 
per gra
Subject 
cpm per 
140 gm r«
Standard
error
o/o
R.P.S., Sutton 90 0.20 28 7.3
Royal Marsden Hosp«, Sutton 83 0.11
•
15.4 12.4
D.E,R.E., Dounreay 220 0.95 133 2.53
Win frith 175 0.90 126 • 2.43
A.E«E«, Windsoale 141 0.872 122 2.30
General Infirmary, Leeds. 80 1.33 186 1.36
A.E.R.E., Harwell 138 1.36 190 1.67
MERLIN - scanning 137 0.82 115 2.40
- chair 133 1«17 164 1,75
CHAPTER 4 : The determination of Iron Absorption and Turnover Rates 
in normal Adult Maleso
Introductions
The earliest method used to measure the retention of iron taken 
orally vxas by chemical iron balance studies* Such investigations are 
both difficult and time consuming, and in chemical measurement procedures, 
especially with faeces, there is a tendency to lose iron, so that the 
absorption figures appear greater than they actually are (JOSEPHS, 1958)*
Since the introduction of methods based on the use of radioactive 
iron, balance studios have largely lost favour and iron absorption has 
been followed either by measuring the percentage of the administered 
radioactive iron vjhich subsequently appears in the circulating* blood 
as newly syntiiesised haemoglobin (HAHN et al, 1939) or by dotermiriing* 
the amount of radioactive iron which can be recovered in the faeces 
(DUBAŒI et al 1948, SMITH and MALLETT 1957, BŒNET et al, 1960).
These newer methods are not entirely satisfactory, however. The 
first requires the assumption that a particular fraction of the absorbed 
iron has boon used for haemoglobin synthesis and also includes the error 
involved in dotezmining or estimating to'tal blood volume» The second 
method relics completely on the co-operation of the subject in under­
taking accurate stool collection over a prolonged period, and in any 
event the per cent absorption of iron is often so small that technical 
errors are magnified* There is also the additional factor of the cost 
involved in keeping the -patient in hospital during the period of the 
faecal collection#
More recently a limited number of investigations have been reported 
using -îdiole body monitors (SARGENT 1962, LUSHBAUGtl and HALE 1965, HcKEE 
et al, 1965, PRICE et al, 1965, REIZENSTEIN and BRANN 1965). This 
chapter describes the use of the shadow shield whole body counter to
- 39
investigate iron absorption and turnover in a group of nomal adult 
male subjects.
MATERI/'bS m D  METHODS.
The prototype whole body monitor was utilised. The patients
were monitored in the supine and prone positions as far as possible*
*
Care is required in the selection of normal subjects, to avoid 
the inclusion of non-anaemic but sideropenic individuals. Those 
accepted as normal subjects were symptom-free adult males in whom 
there was no clinical evidence of disease of of alixnentry blood loss 
and whose peripheral blood findings fell within the accepted normal 
range for haemoglobin, packed cell volume (P.C.V.) and mean 
corpuscular haemoglobin concentration (M.CJl.C.) and whose serum 
iron, total iron binding capacity and percentage iron saturation 
levels were also normal a The haemoglobin was estimated by the 
cyanmethaemoglobin method, the P«C«V« using a microhaematocrit, and 
the serum iron and total iron binding by the method of RAMSAY (1957).
The haematological data for the eight normal subjects selected are 
summarised in TABLE 4.1.
After fasting overnight, the subject was given an oral dose of
5 micro C* Fe^^, in the ferric state, in 5 mg, carrier iron, made
up with water to a total volume of 150 ml. After taking the dose
the subject continued to fast for a further hour. Measurement of
59
the whole body Fê radioactivity was made four hours after the 
administration of the oral dose. Further whole body iron radio­
activity measurements were made at intervals of a few days up to the 
twentieth day after ingestion. The four hour count and the twenty 
day count were used to estimate the percentage iron absorption.
In five subjects further whole body counts were made at intervals, 
up to the 159th day post ingestion and the body iron turnover measured.
In five subjects, to measure the effect (on the whole body counting 
rate) of redistribution of Fe within the body, measurements were made 
immediately after the administration of the oral dose and subsequently
— 40 —
TABLE 4.1
HAEfriATOLOGIGÆ DATA FOB THE H0R4AL SUBJECTS
îase ‘ Hb G/100 ml.
PGV
o/o
Haïc
o/o
Senmi Fe 
ug/lOCml.
T.I.B.C* 
ng/lOO ml*
Saturation ; 
o/o
1* 15*0 44 34 170 330 51
2. 15*7 46 34 120 350 34
3« 16*1 48 34 140 345 41
4. 16*3 47 35 115 345 33
5. 15.1 43 35 145 381 38
6. 14*9 44 33 ■ 170 405 42
7. 15*6 46 34 112 381 29
a 14*2 42 34 105 285 37
at intervals up to six hours post ingestion*
R E S U L T S
The variation in vÆiole body counting rate in the immediate post 
ingestion period (and the effects of these changes on percentage iron 
absorption) are shoxm in Table 4*2. A general trend to lower steady 
counting rates can be seen* This can be attributed to the small 
size of the detector xdiich is less efficient X’Æien the radioactive 
material is some inches off the centre line and also to variations of 
response due to depth» The uncertainty in the percentage absorption 
values due to the initial variation is trivial, however, compared m t h  
the biological variation» The percentage absorption has been 
calculated for each subject using each initial value. The mean value 
and spread are given in TABLE 4*2 A maximum spread of 4- 1 = 9 per cent 
was observed compared with a range of 4*3 - 19.4 per cent in the absorp­
tion values for these five normal subjects.
The pattern of radio«iron elimination is shown in Table 4.3 in which 
are listed the serial wiiole-body radio-iron measurements and percentage
retention values frcm day 0 to day 20, in five subjects» The major 
part of the radio-iron excretion occurs between day 0 and day 7» However, 
from day 8 or day 10 to day 20 the rate of loss iron expressed as a 
percentage (of day 8 or day 10 value) per day is respectively 1.7, 1.1,
3*7, 1*9, 2*1 per cent per day. These values are an order of magnitude 
greater than the long-term turnover values shovjn in Fig* 4 = 1 and pre­
sumably indicate that significant losses are occurring» In particular, 
the retention between days 4 to 10 is still changing appreciably»
Because of these factors, day 20 was selected as the second reference 
point .‘for calculating iron absorption. Tie whole-body radio-iron 
count at day 20, corrected for radioactive decay and expressed as a 
percentage of the four hour count is taken as the measure of iron uptake* 
The results obtained in the eight normal subjects are shovm in Table 4.4* 
The mean iron absorption is 12.0 per cent, the range being 5*8 per cent 
to 19.3 per cent.
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Ml ole Body
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Fe Activity Iron
Absorption
o/o
At 4 hours
C »3p gXTLa
At 20 days
C a O ain. a
La : 30490 4364
':
: 14,51
i» 33377i 51481 15.4
L 10947 1 1403 12.91
: s 1 31481 I 2920 1 9,3
U 5777 j 1115 ! 19,31
i« I 1323 116.4 8.8
i
a j 24768 1443 I 5,8
« i 20920 2005 9.5
TABLE 4s5 illustrates the difficulty in obtaining even a short 
term total faecal collection in ambulant subjects. In this group, 
five day stool collections were made and the faecal radio iron 
content measured. The figure for iron absorption obtained by 
subtracting the radio iron excreted from the dose administered was 
compared with the percentage absorption calculated from the day 5 
whole body count. It should be stressed that the patients were 
in a general medical ward, not a special metabolic studies unit, 
that all of them were freely ambulant and that no special effort 
was made by the nursing staff to supervise stool collections.
The results of the five long teim studies are shovm in FIGUiffi 
4,1. The whole body iron counts for each patient from day 20 onwards 
are shovm plotted on a semilogarithmic scale. The total body radio 
iron loss expressed in this way appears to be linear and the best 
straight line for each set of readings was computed by least squares 
fit using a DEUCE computer. The radio iron loss in the five subjects 
ranged from 0.04 per cent per day to 0.26 per cent per day, with a 
mean of 0.15 per cent per day,
DISCUSSION,
Factors which influence the percentage absorption of radio iron 
are the presence of food in the stomach, the amount of carrier iron 
present, the total volume of the administered dose and, possibly, the 
nature of the iron ion, i.e. ferrous or ferric. In an endeavour to 
avoid such induced variations an oral dose 'vhich is standard in 
respect of ionic state, carrier iron content and total volume v:as 
used, and which is given with the subject in the fasting state, A 
dose of iron comparable with the amount of iron available in the 
normal diet was given. The estimated iron content of a full meal 
is a}oout 5 milligrams (PIREIO-BIROLI et al, 1958). The ferric ion 
has been used as most food iron is in this form. (SOREiïSEN, 1964),
The absorption figures obtained are similar to those obtained by 
other workers using whole body counting techniques (VAN HOEK and
— 42 w
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and C Œ m n  1961, LÜSHBAUGH and HALE 1965, KcKEE et al, 1955, PRICE 
et al, 1965), These results are shoivn in Table 4,6, The practice 
of these workers has been followed in using the four hours post 
ingestion count as the 100 per cent value. However, the changes 
obtained in the present counting system from early redistribution 
effects did not exceed 16 per cent in any of the subjects studied.
This degree of change does not cause ajsignificant alteration in 
the ultimate iron absorption result so that the 100 per cent value 
could equally well have been ‘obtained from the immediate cour.t.
If, as suggested by the results reported here, there is a 
significant continuing loss of iron up to day 20 this may be of 
considerable practical importance. In particular, the high 
retention values (Table 4,3) on day 4 compared with those on day 6 
would seem to indicate that methods based on a 5 day stool collection, 
and possibly a 7 day stool collection, may produce over-estimates of 
the percentage absorption, ■ In view of the limited data obtained, 
since these were almost incidental to the object of this study, 
further investigation is being made in measurements currently in 
progress.
The body turnover results obtained correspond well with those 
of other workers using %diole body counting (KcKEE et al, 1965, PRICE 
et al, 1965, REIZERSTEIN and BRANN 1965). These results are showu 
in TABLE 4o7« Host workers using whole body counting techniques 
have expressed radio iron loss as a single exponential function, as 
we have done. This mode of expression, implying as it does, a single 
completely miscible total iron pool with a constant rate of absorption 
and excretion is not strictly correct. It is however, the best 
approximation which can be made, as accurate mathematical representation 
of the complex multiple pool system which actually exists, would 
require observation of total body activity over a period of several 
years to eliminate the influence of pool shifts on body radio iron 
loss* This is, .of course, impossible because of the short half-life 
of
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The development of the whole body mord tor has provided a simple 
and accurate method of measuring the body retention of an administered 
tracer dose of making absorption and subsequent long term iron
turnover estimations possible in a single clinical study. The 
investigation makes no great demands on the subject, neither requiring 
frequent venepunctures nor the collection of excreta and we feel that 
whole body counting is now the method of choice for studying gastro­
intestinal absorption of iron and body iron excretion.
Oral iron absorption and iron turnover rates have been determined 
in normal adult males using a shadow shield whole body counter. The 
ferric ion was used, a dose of five yuo being given in 5 mg. carrier
iron.
The four hour and twenty day counts were used to estimate the 
percentage iron absorption. The reasons for selecting these counts 
are discussed. In the 8 subjects studied iron absorption ranged from
5.8 per cent to 19.3 per cent with a mean of 12«0«
Iron turnover studies were carried out in 5 subjects, the periods 
of observation extending from 80 to 156 days. Iron losses ranged 
from 0.04 to 0.26 per cent per day with a mean of 0.16 per cent.
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CFYJPTZR 5: SUCCINIC ACID and IKCU ABSORPTION
In a study of oral iron uptake using solutions of fourteen iron 
preparations BRISE and HALL BERG demonstrated that there were great 
differences in the absorbability of different iron ccmpounds (BRISE 
and TiALLBERG 19G2oa«)o More iron was absorbed from a solution of 
ferrous succinate than from any other compound, including ferrous 
sulphate. The absorption of iron from tablets containing ferrous 
succinate was not greater than from ferrous sulphate tablets, however.
Because of these findings it was suggested that succinic ions 
per se influenced the absorption of iron and furhher experiments 
were carried out to test this hypothesis* (BRISE and H/bLBERG,
1962, be)a In these studies the addition of succinic acid to 
solutions of ferrous succinate was shoivn to increase iron absorption, 
the increase being proportional to the amount of succinic acid added. 
Intravenously administered succinic acid was also shovm to increase 
the absorption of iron from ferrous sulphate solutions given orallyo
In an attempt to utilise these observations in practical 
therapy a commercial preparation, Ferram;sui-S, containing ferrous 
succinate and succinic acid in tablet form has recently become 
available.
This chapter describes an investigation of the effect of 
succinic acid on the oral uptake of iron, using Fe^^ labelled 
ferrous succinate and the prototype whole body monitor to measure 
iron absorption.
5ol Materials ar^ d Methods.
Liquid preparations of ferrous succinate were used to avoid 
the possible effect on iron absorption of variable disintegration 
of a pill coating. The ferrous succinate was labelled with Fe^ '" 
so that each dose contained 10 micro G« radioactivity.
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Absorption was studied at two levels of iron dosage, 5 mg 
elemental iron (20 mg- ferrous succinate) and 37 mg elemental 
iron (150 mg ferrous succinate). To one half of the doses of 
ferrous succinate, free succinic acid was added in amounts 
based on the optimùn ratios (BRISE and flALLBERG, 1962, b) so 
that there were in all four separate preparations containing;-
1) 20 rag Ferrous succinate
2) 20 rag Ferrous succinate vjith 15 rag succinic acid.
3} 150 rag Ferrous succinate
4) 150 rag Ferrous succinate with 110 rag succinic acid,
A small quantity of ascorbic acid was added to each dose to prevent 
oxidation of 'the ferrous ion.
Non-anaemic, syraptoraless, adult subjects were selected for the 
investigat ion «
The doses of iron were given in the early morning after an
overnight fast. The iron solution was taken directly from a
small beaker which was then rinsed with tap water and the rinse
water also taken. The rinsing procedure was repeated so that
the total volume ingested was 150 ml. No food or drink was taken
for two hours aftenvards. The percentage absorption of iron was
59calculated from the four hour and twenty day whole body Fe 
radioactivity counts as previously described (TILL and BODDY, 1966 
and chapter 4).
Each subject was first given a solution containing ferrous 
succinate only and the iron uptake measured. After an interval 
of about two months the uptake study was repeated, the subject 
being given on the second occasion a solution containing the same 
quantity of ferrous succinate as before but with the appropriate 
amount of free succinate acid added. The two iron uptaice results 
were then compared.
To study the effect of intravenous succinic acid on oral 
iron absorption a sterile solution of pH7 containing in each
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millilitre 30 mg of succinic acid and 6 mg of solium chloride was
used. Hie subject was first given an oral dose of 5 ng ferric
59iron labelled m t h  lOuc of Fe and the percentage iron absorption
measured by whole body counting. Th*70 months later a similar oral 
59dose of Fe labelled iron was given but on this occasion it was 
preceded by the slow intravenous injection of 5 ml of the succinic 
acid solution, the injection stareing five minutes before the 
administration of the oral iron dose.
5 «2 Results.
The absorption figures of the five subjects who were given 
the 20 mg doses of ferrous succinate are sho'wn in Table 5d. In 
four subjects iron absorption was increased by the addition of 
succinic acid. The mean absorption from the doses containing 
ferrous succinate only was 8.5 per cent (range 3.0 to 13d per cent) 
and the mean absorption from the doses containing 15 mg of added 
succinic acid was 13.0 per cent (range 5«9 to 17«2 per cent). 
Statistical analysis of the two sets of results using the STUDENT t 
test gave a value for T of 1.82, which indicates that the differences 
are not statistically significant.
In six subjects iron absorption frcm solutions containing 150 mg 
ferrous succinate was studied. Only two showed increased absorption 
from the doses containing the added succinic acid. In the remiaining 
four the percentage iron absorption fell. The mean iron absorption 
from the solutions containing 150 mg ferrous succinate only was 7«2 
per cent* (range 0.2 to 15.0 per cent) and the'mean absorption from 
the doses containing 150 mg- ferrous succinate plus 110 mg succinic 
acid was 6,0 per cent (range 2.0 to 8 «2 per cent)» The results are 
shovjn in Table 5,2, The STUDEIfT t test gave a value for t of «0.46 
shomng that no statistically significant difference was observed.
The results obtained from the six subjects who took part in 
the intravenous succinic acid absorption test are shown in Table 
5 = 3. The mean absorption from the 5 mg doses of ferric iron was
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T.%LE 5.1
The Effect of 15 mcf Suoainic Acid on the Absorption* " ' #" I#"'*     n; ', W *■■■»««    I nililini
of 20 mcf Ferrous Succinate.
Ci\SE
PERCENTAGE lECN ABSORPTION
20 mg Ferrous Succinate 20 mg Ferrous Succinate
-t 15 ncr succinic acid.
1 12.0 17,2 !
2 10.4 8.7 j
3 3.0 5.9 ;
4 1 4,1 16.6 :
s
j 13,1 16.5 i
TABLE 5,2
The Effect of 110 mg Succinic Acid on the Absorption 
of 150 ma Ferrous Succinate, .
j
1 Case
PERCENTAGE IRON ABSORPTION
i
1
!
.. ....
150 mg Ferrous Succinate 150 mg Ferrous Succinate i 
+ 110 mg Succinic Acid.
!
I 1 5=2 2.0 1
! 2 2.5 7.3 i
! 3 0.2 8..2 :
i 4 10.7 ■ 8.0 '
; 5 9.8 3.3
: 6 15 6.7
TABLE 5.3
The Effect of Intravenous Succinic Acid
on Oral Iron Absorption.
CiASE PERCENTAGE IRON ABSORPTIŒ
5 mg Ferric Iron 150 mg Succinic Acid I.Vi 
followed orally by 
5 mg Ferric Iron»
1 9,0 13,2
2 14.5 13,4
3 9.3 14.4
4 12.5 2o4
5 19.3 7-6
6 12.1 7,0
12,8 per cent (range 9,3 to 19,3 per cent), VAien the oral dose 
of iron was preceded by the intravenous injection of 150 mg succinic 
acid the subjects showing a decreased iron alescrption. The STUDENT t 
test gave a value for t of -1,12, indicating that any effect was 
statistically insignificant,
Ti'fo patients with rheuiriatoid arthritis were given oral doses of 
5 mg labelled ferric iron both with and without intravenous succinic 
acido. In one the iron absorption remained virtually unchanged, 1,7 
per cent without succinic acid and 1,9 per cent following intravenous 
succinic acid. The second patient had 10,7 per cent iron absorption 
from the 5 rag ferric iron alone falling to 0,6 per cent when the oral 
dose was preceded by intravenous succinic acid.
5=3 Discussion.
The investigation was designed to assess the influence of 
free succinic acid on the oral absorption of iron at both physiological 
and pharmacological dosage levels.
Five milligramir.es was chosen as the physiological dose because 
this is roughly the iron content of a normal full meal (PIRZIO - 
BIROLI et al) while 37 mg was regarded as a satisfactory therapeutic 
dose of iron (KERR and DAVIDSCN, 1958),
All doses were of uniform volume and were given to the fasting 
subject to eliminate as far as possible the influence of local 
gastro-intestinal factors on iron absorption.
Earlier comparative studies of iron absorption have usually 
been based on the determination of haeraoglobin regeneration in iron 
deficient patients during iron therapy (FUULERTŒ 1934, HALER 1952,
VEELL and VILTER 1954}» The haeiaogTobin regeneration rate is however 
influenced by many factors, including the severity of anaemia, state of 
the iron stores, continued bleeding*, the presence of infection, which 
malce interpretation of the results difficult. By using a whole body 
monitor to obtain a direct estimate of iron absorption in non-anaemic 
subjects these main sources of error have been avoided»
VJhile the present results would appear to contradict those of 
BRISE and tIALLBERG, attention should be dravm to the difference in 
the methods used to measure iron "absorption”, The measurement 
of iron uptake with the whole-body "monitor" represents total body 
uptake « . As BRISE and HALLBEB3 emphasise, their method does not 
estimate total absorption but measures only the fraction of absorbed 
iron utilised in haemoglobin formation» In this difference may lie 
the apparent conflict of the findings» BRISE and HilLLBERG®S observed 
increase in iron utilisation could be explained by succinic acid 
increasing either the availcibility of iron to the marrow or the 
rate of utilisation of iron by the marrow» Their findings that 
intravenous succinic acid increases the utilisation of orally 
administered iron also suggests that 'Idio effect of succinic acid 
is not a local one on the gastro-intestinal tract»
The administration of a single tracer dose as in the present 
studies may require comparison with the ten doses each given on 
successive days as reported by BRISE and HALLBERG, The possibility 
that successive doses of succinic acid may have an increasing effect 
cannot bo excluded» Further, these authors showed that individual 
variations in utilisation may be about 16 o/o' with successive doses 
and they estimated that vrith single doses the variations may be about 
d; 35 o/oo If similar conclusions apply to absorption, the effects 
of succinic acid may not bs sufficiently large compared with the 
biological variation to be readily detected» To test these hypotheses, 
a new series of investigations is in progress i-hich will involve the 
administration of successive daily doses of iron and *tho simultaneous 
measurement of utilisation and absorption»
5.4 Summary B
The effects of succinic acid on iron absorption in non- 
anaemic, symptcmless, adult subjects have been examined using a 
whole body monitor. Hsro levels of iron dosage, 5 mg» elemental
« 49 *
iron (20 lug» ferrous succinate) and 37 mg= elemental iron (150 nig* 
ferrous succinate) were studied with oral succinic acid doses of 
15 mg* and 110‘mg= respectively* The effect on absoriction of a 
slow intravenous injection of 5 ml» of succinic acid solution (30 mg. 
succinic acid and 6 mg. sodium chloride per millilitre) preceding 
oral adirdnistration of, 5 mg» ferric iron was also examined* It is 
shovm that the effect of succinic acid was not sufficiently large 
compared with the individual biological variation to be statistically 
significant.
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CHAPTER 6s The Retention and Rate of Excretion of Vitamin
in Patients with Pernicious Anaemia and in 
a noiattal subject following Intravenous 
Administration of Radio-Vitamin B
12 o
6.1 Int roduct i on;
Administration of radio-vitamin B^^, labelled with one of
the radioactive isotopes of cobalt, enables the retention and rate 
of loss of vitamin-B^g to be measured for example by urine or faecal 
monitoring or by whole «body monitoring. VJhen knowledge of the 
excretion route is irrelevant, x*jhole«body monitoring is the method 
of choice since the collection of urine and faeces over prolonged 
periods of time is usually impracticable while, using the whole- 
body monitor, the patient does not require hospitalisation and can 
be examined as an out-patient.
The total, body content of vitamin in nonual subjects is 
about 2000 « 5000 ^ ug (Adams, 1962 and Grasbeck, 1359), while in 
anaemic subjects the corresponding range is about 200 « 500 ^ g 
^12 (Ghasbeckf 1959)»
It has been suggested, (Reizenstein and co-workers, 1962,
1964 and 1966* and Reizenstein, 1366), as discussed in Chapter 7,
that, in nozmal subjects, administration of a tracer dose of
labelled B does not lead to excretion patterns and rates of 
‘ 12loss typical of the natural pre-existing in the body» The 
validity of the common assumption of metabolic and isotopic 
equilibrium was questioned»
If an anaemic patient, whose stores are virtually depleted, 
receives an intravenous dose of about 5000 ug of 1 aloe lied vitamin 
B^^f his excretion pattern, after the steady state is established, 
should closely follow that of natural in the normal subject 
since the fraction retained of the labelled dose (about 10 o/o) 
is the greater part of his body content of B^^* The later
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excretion rate, expressed as per cent loss per day, should be of 
similar magnitude to the rate of loss of natural in the normal 
subject. Therefore, if the "steady-state" is reached in a 
comparatively shorb time (say'l to 2 months) and the subsequent 
rate of loss can be adequately described by a single exponential 
term, then it seems reasonable to assume that vitamin meta3oolism 
approximates more closely to a single-pool system, for v/hich tlie 
assumption of isotopic equilibrium is justifiable, than to a 
multiple-pool system, for which the assumption is not justifiable. 
Supporting evidence would be obtained if a normal subject, given 
the same intravenous dose, presented a late excretion rate, as per 
cent loss per day, of similar magnitude to the rate of loss of 
anaemic subjects since this implies that the loss is from a single 
body compartment and is proportional to the level of body stores.
6 « 2 Methods:
Fourteen patients were studied, one of wiiom was normal having 
a normal serum vitamin level and no symptoms of anaemia. Thirteen 
were B^^ deficient all having subnormal serum vitamin level and 
megaloblastic erythropoiesis on marrow biopsy smears » Some of these 
patients had presented with symptoms of anaemia; others vho were not, 
or only mildly, anaemic had presented with signs suggesting B^^ 
deficiency such as glossitis* Additional diagnostic investigations 
lead to the diagnosis of post-gastrectomy megaloblastosis due to 
deficiency (Subject HcK« 1) and to the diagnosis of Addisonian 
pernicious anaemia in the others. Hie pretreatment haematological 
data are summarised in Table 6„1 =
A parenteral dose of about 5000 jag of vitamin labelled
with either cobalt-57 or cobalt-58, was administered to each subject.
In eight subjects the vitamin was in the form of hydroxocobalamin, in 
one subject cyanocobalamin and in one subject co-enzyme The
remaining four subjects received doses of cyanocobalamin (cobalt -58)
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TABLE 5,1
Pretreatm ent Haematoloq-ical Data
Subject Sex Age
Yrs.
Haemoglobin 
gm o/o
Serum B. 
uug/ml
Erythropoiesis j
H M 47 10.0 25 Megaloblastic
Mo.D F 70 6.9 25 tt
Hc.K.l. M 71 10.1 58 M
B.2. F 34 6.4 25 «
P. M 57 8.5 25 H
0. H 51 7.9 26 H
3.1. F 62 5.1 25 «
4.2. F 41 11.1 25 n
4.1. F 66 10.7 59 H
Ic.K.2. M 74 5.7 25 H
r F 69 5.6 25 M
L F 51 12.0 25 M
Ar M 45 5.1 44 H
A M 1 42 14.8 350 -
and of hydroxocobalamin (cobalt-57) providing a double isotope study. 
Eight subjects had received the dose before this study was established. 
They were, nevertheless, of interest since the long-teim rate of 
excretion could be measured.
The retention of the administered was measured in the 
prototype whole-body monitor over periods of time presently up to 
441 days. Measurements were made with the subject in the supine 
and prone positions where this was practicable,
6.3 Variation of the initial count ing- rate due to redistribution in
the body:
It has been suggested (Reizenstein, 1959 b) that the injection 
of even 0,01 o/o (0,5 ug) of the total body is enough to disturb 
the steady state temporarily, since the total plasma contains only 
about 0.03 o/o (1.5 ug) of the total body B^^. The initial plasma 
clearance is extremely rapid (Conkite et al, 1959) with a biological 
half-life of about 2 min. At later times half-lives of about 6 days 
(Reizenstein, 1959 b) and of 5,14 days (Adams, 1963) have been reported# 
Consequently the largest variation of the counting-rate due to changes 
in the distribution of the labelled B^^ in the body may be expected, 
in the first few hours after administration. To examine the 
magnitude of this effect in the prototype monitor, the noimal subject , 
was monitored shortly after administration at 2^ hours and at 4^ - hours 
post-administrât ion. For ccciparison, a urine sacple was then passed 
and collected. The loss of labelled was then estimated by a 
further whole-body measurement and by monitoring the urine. Subsequent 
counts were made 24 hr and 3 days later and comparison made with the 
losses estimated from urine collection over these periods. The results 
are summarised in Table 6,2.
6.4 Results:
The serial counting-rates obtained, and the percentage retention
— 53 •»
TABLE 6.2
ae after 
;ial 'vÆiole- 
r count
Made-body 
(supine and prone) 
cpm
Loss 
(o/o total 
injected)
Urine loss 
(o/o total 
injected)
............
Cumulative
Collection
Period
Cumulative 
urine loss 
(o/o total 
injected)
hrs 20507
hrs 20915 0^,3o/o "
hrs 20902 - -
:______ .,
-
hrs 9594 53.8 46.4 0 - 6  hrs 46.4
hrs 5719 67.7 13.8 6 -30 hrs 60,2
- - 3.3 30 -48 hrs 63.5
ays 4920 76,3 2.6 48 -72 hrs 66.1
each represents,■ are presented in Table 6.3 for the anaemic subjects 
and in Table 6.4 for the normal subjects all of whom received a 
single isotope. The results to date of the double isotope studies 
are given in Table 6.5. For each subject, the regression line and 
regression coefficients have been computed assuming that the data 
after about 30 days are adequately described by a single term.
The equation obtained, the periods of time covered, the rates of 
loss (per cent per day) and the standard error of the regression 
coefficients are summarised in Table 6.6.
A comparison of the retention pattern of the normal subject 
with that of a typical anaemic subject is shown in Fig 6.1.
6,5 Discussion:
The overall variation in the initial count ing-rate (0 - 4;^- hrs) 
(Table 6.1) was about 2 per cent and the standard error was about 
1 per cent. As these measurements were made on a normal healthy 
subject, having an appreciation of the need for reproducibility, 
the variation for other subjects may be greater. It seems fairly 
certain, however, that the variations are significantly less than 
those reported in the discussion of metabolic equilibrium by Heinrich 
.(1964) of about 40 o/o and by Reizenstein et al (1961) of over 20o/o 
following oral administration of
The general pattern of excretion of the anaemic subjects (Table 
6.2) and of the normal subject (Table 6.3) following a single dose 
of are remarkably similar as is shown in Fig 6,1. About 8-10 o/o 
of the administered dose is retained at about 1-2 months after injection 
and the subsequent loss with time can be adequately described by a 
single exponential term (correlation coefficient 0,8) with a mean 
standard error of about llo/o.  ^The equivalent standard error quoted 
by Heinrich (1964) was about 33 o/o.
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Ti\BLE 6.4
Retention in a Normal Subject following a single intravenous dose 
of 50C0 ^ ug vitamin
1 SUBJECT A (H.M)
Days cpm
o/o
Retained
r
0 20774 100 1
1 ' 6714 32.4 1
3 4920 23.7 1
14 3409 16.4
48 2342 11.3
70 2234 10.8
101 1982 9.6
129 1845 8.9
161 1769 8,5
192 1689 8.1
210 1609 7.7
238 1557 7,5
269 1528 7.3
282 1459 7.0
325 1457 7,0
381 1304 6.3
402 1 1363 6*6
430 1 1256 6»0
(H, K) ~ Hydroxocobalamin, male subject-
TABLE 6 05
Retention in anaemic subjects following double isotope doses of 5000 ug 
labelled vitanain
Subject k (f ) SUBJECT (P)
Bays cpm
G
0/0 c 
Retained cpmH
0/0 H 
Retained
cpm
C
0/0 C 
Retained cpmH
0/0 H 
Retained
0 991 100 1409
:
100 ^ 1172 100 1852
1
100
3 128 12«9 503 35«7 1 107 9,1 365 20.0
7 112 11.3 t» — ( 92.3 7.9 #*# **
3 - - 291 20.6 i - M ##
10 104 10,5 — I 89.5 7.6 - »
14 w trt 276 19.6 Î M 225 12.1
15 92.0 9=3 m* I M a* —
21 95,5 9.5 255 18,1 i 82,0 7 = 0 210 11.3 !
28 83.5 8.4 243 17.2 1 77 = 0 6.6 208 11.2 !
35 80.9 8.1 238 16.9 71.5 6.1 195 10.5 :
42 81.5 8.2 240 17.0 72,0 6.1 193 10.4.
49 79.2 8.0 229 16.2 . 70,1 6.0 191 10,3
56 78.3 7.9 229 16.2 68.2 5.8 184 9,9
63 75.1 7.6 215 15,3 72.1 6.1 170 9.2
70 77.2 7«8 212 15.0 74.0 6.3 172 9.3
77 74.0 7,5 229 16,2 69.8 5.9 172 9.3
84 75.1 7.6 215 15.2 68.5 5,8 173 9.3
91 73.3 7.4 207 14,7 65.5 5.6 171 9,2
98 73.4 7«4 201 14.3 65,6 5.6 174 9.4
105 74.1 7.4 198 14.1 67.4 5.7 175 9.4
112 71.2 7 p 2 - 67,7 5o8 1
119 — 193 13.7 - M 163 8.8
126 75.1 7«6 •rt ** 63,2 5,4
147 - — 201 14.2 M » 158 8.5
154 72,1 7.3 M « 58.1 5.0 -
182 a* 195 13.9 w _ 150 8.1
18 9 52,4 6,2 - — 60.7 5.2 - -
c “ cyanocobalamin 
h = hydroxocobalamin
WiBLE 6„5 cont’d
SUBJECT Ar (K) He, D. (P)
)ays cpm
C
o/o c 
Retained]
1
Days 1 1cpm
H
o/o H 1 
Retained]
—
Days cpm
C
o/o C 
Retained
Days cpm
H
d/o H
Retained
0 1172 100 1 ^ 14896
li
100 25 271 100 0 11214 100
15 122 10.4 j 28 j 700 14 a 3 1 59 239 87.7 28 728 6.49
43 107 9.2 1 56 1 644 13,2 i3 84 239 87.7 70 650 5.80
71 94.8 8.1 1 97 635 13,0 \ 122 229 84,4 99 626 5.58
99 81,5 7.0 i 118 583 11,9 153 228 84.0 127 611 5.45
âO 88,0 7.5 146 588 12,0 I! 178 208 76.7 161 565 5 . 04
51 |71«9 6.1 174 558 11.4 206 184 67»8 183 565 5,03
39 |84,0 7.2 202 534 10.9 224 217 79,9
L7 |73.3 5.2 255 182 67.1
15 i?S,2 6.2 283 1 201 74.1
'
TABLE 6,6
jject Time period 
. after administration
Equation of Regression ' 
Line >
1
Rate of loss 
o/o /day
Standard error 
(o/o) of rate 
of loss
ismic subjects. single isotope studies;
dc.i. 35 « 441 y “ 2.4434^1.11x10 x Call • ± 8 = 7
. s 35 - 376 y ~ 4.4479-la35x10 ^x 0ul4 ± 7*4
»V t : 27 « 386 y = 4,4563-1.27xlO"®x Owl3 ± 11"%
, V 66 - 325 y = 4.5623-1.04x10"^% 0*10 ± 13,8
1 50 - 337 y = 3.8043-1.91x10 % 0=19 ± 18.3
I 35 - 365 1 y = 4,4024-1.09x10"®% 0,11 ± 8,2
j 35 - 365 y = 4.3763-1.30x10"®% 0*13 i 3*8
K.2. ; 61 - 253 y = 4.6663-1.39x10"®% 0,14 t 20,8
; 73 - 488 y = 4.5577-0.90x10"®% 0.09 ± 9.5
emic subjects. double isotope studies:
28 " 154 ■ y = 2.1501-1.44x10"®% 0,14 i 12.1 1
28 *• 119 . j y = 2.8599-1.59x10"®% 0.16 ± 13-3 1
42 *■ 154 • 1 y =  la8348-1.64x10"®% 0,16 ± 14,8 j
0 j 42 — 147 1 y = 2.3843-1.77x10"®% 0,18 ± 32,9
nk/g 1 43 " 245 j y = 2.2134-1.72x10"®% 0,17 ± 26,1 1
i. ■ 56 -i 202 j y = 2.6653-1.34x10"®% 0,13 1 ±
)wC. j 59 - 283 y = 4,5539-1.10x10"®% 0.11 ±27.0 1
' 70 - 183 i y = 1.8552-1.36x10 ®x 0.14 . ±10.5
nal subject; 1{
' 70 - 430 1 y = 2a3861-la41x10 x I 0.14 ± 7.4
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6,5.1. Probable signifioance of retention at 1-2 months:
The initial losses up to about 1-2 months is clearly not 
significantly influenced by the level of body stores as the retention 
of the normal subject was the same as that of the anaemic subjects. 
This finding is almost certainly due to the size of the administered 
dose (5000 -jxq) which produces non-physiological conditions. The 
plasma content of normally about 1.5 yig, and less in anaemic
subjects, so that the intravenous dose presumably "floods" the plasma 
with consequent rapid initial clearance by the kidheys, ^The large 
urinary losses of the normal subject (Table 6.2) appear to be in 
accordance with the latter suggestion which implies that this is 
the main route of initial excretion. Clearance from the plasma to 
stores during this time may be limited by the rate at which the body 
stores can take up Since the uptake by stores is about lOo/o
of the administered dose •vdiile about 90o/o is excreted, largely by 
the kidneys, the plasma/stores transfer rate is apparently about 
1/10th of that of the plasma/kidney transfer rate. This conclusion 
may be valid only for the present administered doses and periods of 
time.
6,5.2 Probable significance of the late excretion pattern.
It is apparent from Fig 6,1, the regression lines and standard 
errors of the regression coefficients (Table 6.6), that a single 
exponential term adequately describes the late excretion pattern in 
the normal and anaemic subjects. Consequently, the loss can be 
frcm only a single compartment since it is unlikely that two or more 
compartments would have identical excretion rates. For a single body 
compartment, the assumption of metabolic (and isotopic) equilibrium 
is justified.
The late excretion rates, as per cent per day, range frcm 0,09 
to 0.19 per cent per day, A similar range from whole-body monitoring
was reported by Bozian et al (1963) and a more complete comparison is
55 -
made in chapter 7, Ko significant difference was observed between 
the excretion rates of the anaemic and normal subjects. The 
quantities of exreted per day are apparently proportional to 
the level of the body stores. It may be inferred for both the 
normal subject and the anaemic subject with no significant source 
of addition that, at this time, the rate of transfer from stores 
to plasma is equal to that of transfer from plasma to kidneys. It 
seems unlikely, therefore, that vitamin deficiency or pernicious 
anaemia, at least in the present subjects, is associated with an 
obvious fault in metabolism.
The retained B^^ represents almost the total body content of 
the vitamin in the anaemic subjects. The percent loss per day of 
the labelled should be closely similar to that of the natural 
B^g. If the rate of loss of a tracer dose (about 1 yrg B^^) does 
not represent that of natural body (Reizenstein et al, 1962, 1964 
and 1966 and Reizenstein, 1966) then a different rate of loss would be 
expected in normal and anaemic subjects to whom a tracer dose of B_ _ 
had been administered compared with the rates of loss obtained in the 
present study. In fact, the rates of loss observed by Bozian et al 
(1963) using tracer doses are virtually identical (0,09 - 0.23 per 
cent per day) with the present values. Further, in the present 
studies, the identity of the late rate of loss of labelled B^^, of 
the normal subject equivalent to about 10 per cent of his total body 
^12' that of the anaemic subjects also suggests that equilibrium 
with natural exchangeable indeed established.
6.5.3 Double isotope studies; the retention and the excretion 
rate of hydroxocobalamin and cyanocobalamin.
Each of the anaemic subjects in the double isotope study received 
an initial injection of about 5000 ^ ug cyanocoabalamin labelled with 
cobalt-58 followed at a later time by an Injection of about 50C0yig 
hydroxocobalamin. Allowance was made for the contribution of the 
Compton region of the cobalt-58 gamma ray spectrum to the photopeak 
region of the cobalt-57 spectrum. The subject was monitored
- 56 -
immediately priot to the injection of cobaIt-57 and the fraction;
counting-rate in cobalt-57 photopeak region evaluated from the 
counting-rate in cobalt-58 photopeak region
cobalt-58 whole-body spectrum, Honitoring was repeated shortly 
after the injection of cobalt-57 and this and subsequent counts 
were corrected for the cobalt-58 contribution by subtracting the 
product of the cobalt-58 photopeak and the fraction obtained pre­
viously, It is obviously necessary to assume that this fraction 
is not grossly affected by any subsequent redistribution of cobalt- 
58 vitamin
Table 6,5 shows that the overall pattern of excretion is 
similar to that of the single isotope studies- Further, the rate 
of loss of the initial dose during the month after injection of the 
second 5000 ug dose does not appear to differ significantly from the 
rates of loss in the single isotope studies during the equivalent 
period of time. The rate of loss of the second dose during this 
tirae, however, is about four times greater. It seems reasonable 
to assume, therefore,' that at the time of administration of the 
second dose the major part of the retained initial dose is no 
longer in the-plasma and has, presumably, been transferred to 
stores. This situation is evidently reached not later than 
seven days after the initial administration in subjects K and L.
This conclusion is in agreement with the results of Moll in (1959) 
for administered doses of 0.04yig vitamin
The retention of hydroxocobalamin appears to be significantly 
better than-that of cyanocobalamin, conflaming similar findings 
(for example. Glass, G.B, et al (1961), Killander and Schilling 
(1961), Adams and Kennedy (1965)), Measurements have not yet 
been made with the order of administration reversed but if plasma 
and stores levels affected the observed retentions then it should 
be the first dose rather than the second dose which is preferentially 
retained, A comparison of the regression coefficients of the late 
excretion regression lines using the Student t test shows that the
- 57 -
respective rates of loss, per cent per day, do not differ 
significantly. Presumably, once the vitamin reaches the stores 
the subsequent metabolism is essentially independent of the 
chemical form or the vitamin, is transmuted to a common form.
6.6 Conclusions :
a) Following intravenous administration of a single dose of 
5000 jug vitamin the retention 1-2 months post-injection was 
the same (about lOo/o) in the anaemic subjects and the normal 
subject. Ko difference was observed in the excretion rates, 
thereafter, (range 0.09 - 0.19 per cent per day) and a single 
exponential term adequately describes the late excretion pattern. 
This implies that metabolic and isotopic equilibrium is then 
established.
b) The similar excretion rates of normal and anaemic subjects 
implies that vitamin deficiency in these subjects is not 
attributable to a metabolic fault.
c) Double isotope studies suggest that the retained fraction 
seven days after administration is largely in the body stores.
d) Hydroxocobalamin is retained to a greater extent than 
cyanocobal amin «
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CH;\FTSR 7: The Validiity of the Assumption of Tracer Equilibrium
with respect to the Excretion of Vitamin
7 tf1 IntroduGt ion:
The validity of the common assumption that the excretion 
rate of a tracer dose of vitamin equals that of the natural 
^12 been questioned in recent years by Reizenstein and co- 
workers, (1962), (1964) and (1965), Reizenstein, (1956) and 
Heinrich (1964) vho suggest that equilibrium might not be 
established even 250 days after adrainistration of the tracer 
dose* Further, tliese authors obtain late excretion rates which 
are significantly different from those of other workers also 
using whole-body monitors and of others using analysis of excreta.
The suggestion by Reizenstein and co-workers that the 
assumption of tracer equilibrium is not justified is contrary to 
their earlier work (for example, Reizenstein, 1959 (a), 1959 (b), 
Grasbeck, Kyb-erg and Reizenstein, 1953 Reizenstein et al», 1951,
Cohn, Lippincott, Cronkite and Reizenstein (1-962 )) which provides 
and cites evidence for, or embodies the assumption of, the early 
Gstablisiuaent' of equilibrium not only with respect to excretion but 
also between body compartments » The rates of loss from the body of 
vitamin obtained in the earlier work differ significantly from 
the later estimates of these authors but are in good agreement with 
those of other workers.
I n  v i e w  o f  t h e  c o m p a r â t i v e l y  l a r g e  a m o u n t  o f  d a t a  s u p p o r t i n g  
t h e  a s s u m p t i o n  o f  e q u i l i b r i u m  a n d  t h e  n u m e r o u s  s t u d i e s  b a s e d  o n  t h e  
v a l i d i t y  o f  t h i s  a s s u m p t i o n ,  e v i d e n c e  t o  t h e  c o n t r a r y  w a r r a n t s  
c a r e f u l  e x a m i n a i i o n «
7a2 Experimental evidence of Reizenstein and co-workers:
The d a t a  o f  R e i z e n s t e i n  a n d  c o - w o r k e r s  a r e  s e l f - c o n t r a d i c t o r y  
i n  s e v e r a l  i m p o r t a n t  r e s p e c t s  « T o  f a c i l i t a t e  r e f e r e n c e ,  r e l e v a n t
— 59 «
data have been collected and are sutTurarised in Table 7«1 with 
the source of the data.
On the basis of the data in Section A of this table, Reizenstein 
et al, (1952) conclude that the higher and, apparently changing 
excretion rate of the tracer shows that "equilibrium is not reached 
within the time studied"*
7«2.1 Examination of premises:
Before dealing with apparent anomalies in the data as a whole, 
the validity of this conclusion and the premises on vjhich it is based 
will be consideredo Examination of the methods used (Reizenstein, 
(1959) and Reizenstein et al» (1962)), shows that the quantities of 
-vitamin administered in both series of experiments were similar 
(about 1 yUg) and all s^abjects were classified as noxmal controls or 
as having irrelevant diseases- An%/ perturbation of the steady state 
resulting from the ad:rdnistered dose of can only be due to ‘the 
presence of additional vitamin and whether it is labelled or unlabelled 
is irrelevant in this respect* Therefore, whatever the effect of a 
tracer dose might be on the rate of excretion of vitamin , it should 
be identical for both series of patients* The method of measuring 
excretion, vhole-body or faecal monitoring of labelled or 
microbiological assay should produce identical results, whether 
equilibrium is established or not, as there is apparently no evidence 
to suggest that vitamin is broken doum and the label subsequently 
lost* This argument leads to the inevitable conclusion that it 
should be fundamentally impossible to demonstrate a difference in 
the rates of loss of labelled and non-labelled B.. in these particular 
experiments* The apparent differences shovm are then presumably due 
to experimental errors, inadequacies in the data, biological variations 
in individuals or groups of individuals, etc*
7c.2*2 Apparent anomalies in the data:
The faecal excretion rate of radiovitamin  ^ (section C, Table 
7wl) (Reizenstein, 1959 a) is essentially constant (0*12 o/o /day) at
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least froci 37 days onwards to 345 days* A standard error of j; 20 o/o 
is qnotedü In view of the alruost inevitable losses which occur in 
faecal monitoring^ the estimated rate of loss is unlikely to be an 
over-estimate^
The whole-body monitoring data (Reizenstein et al=, 1961, 1962,
Cohn, Lippincott, Cronkite and Reizenstein, 1962) are in good agree­
ment vdth those from faecal monitoring. A steady rate of loss is 
apparent from about 5-20 days after adraini strati on and the authors 
specifically state that ”the final slope shows the rate of turnover 
of the absorbed vitamin The excretion rates can be estimated,
from the graphical presentations of Reizenstein et al, 1961, Cohn et 
al., 1962, as about 0*18 per cent per day in good agreement with that 
of Reizenstein et al«, 1952 (TableZl, Section A). The data are in 
excellent agreement with those of Bozian and co-workers, (1963), (1964) 
and (1966) and those of chapter 6, both with respect to the pattern of 
excretion and the laagnitude of the excretion rates.
On the other hand, the interpretation of whole-body monitoring 
data by kinetic analysis (Reizenstein et al. 1964, 1966) (Table 7.1 
section D) apparently suggests that the late excretion rate is about 
0u0362 per cent per day and a constant value is approached not later 
than about 60 - ICO days* Tl'iis data completely contradicts the 
assertion of Reizenstein et al. (1962) that *’a comparison of the 
tracer excretion rate with that of unlabelled 3^^ (0.03 per cent 
per day. Table 7.1 section B) shoized a more rapid tracer excretion 
even 3 years after the administration of indicating that
equilibrium had not been reached’*. The excretion rate of about 
0o036 per cent per day is significantly less than those obtained 
earlier by these authors and, for reasons presented in Section 7.3, 
is almost certainly an underestimate. Further, the determination 
of the excretion rate of non-labelled (Reizenstein, 1959) involved 
the use of tracer and the assumption that equilibrium was established 
in about 11 days. It seems illogical, therefore, to argue that equilibrium 
is not established even after 3 years utilising* this data.
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7.3 Experimental evidence of Heinrich (1964),
The retention of cyanocobalamin has been measured in
three patients over 671 days using a whole body monitor (Heinrich, 
1964).' The data from the individual patients were apparently, 
pooled and an exponential equation of best fit was computed for 
the data as a vjhole. Turnover rates calculated by the present 
author using Heinrich^s equation are summarised in Table 7.2 
Heinrich suggests that metabolic equilibrium is not established 
about the 270th day and obtains a final turnover rate of 0,051 
%3er cent per day. On the other hand, ■ these calculations suggest 
that at 60 days after administration the final exponential term 
contributes over 93o/o of the retention figure at this time.
The turnover rate at 150 days is 0,067 per cent per day compared 
with a final rate of 0.051 per cent per day. Heinrich (1964) 
quotes a standard error for Reizenstein's excretion rate of jr 
33 o/o, and if Heinrich's standard error is of similar magnitude, 
it seems reasonable to assume that the rate of loss is constant 
within the experimental errors not later than 150 days,
7=4 Hhole-body monitoring data of other workers.
60Tlie retention of Co-labelled vitamin B. has been measured 
in three normal subjects, two patients with irrelevant diseases and 
eleven patients with pernicious anaemia up to 668 days (Bozian et 
al», 1963) and up to 1100 days (Heyssel et al 1964 and 1966) « Hates 
of loss obtained are summarised in Table 7.3. These authors find 
that, ’'during the first several we des following absorption or injection 
of vitamin B^^, there are wide fluctuations of cdunts which
probably correspond to redistribution of the vitamin through various 
compartments,“ Further usually after one month and invariably after 
two months in"the case of injected vitamin rate of loss from
the body becomes effectively constant.
A similar excretion pattern was observed (Chapter 6) following 
intravenous administration of about SCCQug of anaemic patients
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TABLE 7,2
Retention and Excretion Rate of Absorbed Vitamin in Man (Heinrich, 
1964) as Calculated by present author;: from
Heinrich's equation: Retention (o/o) = 4- 68
Days afterg^ 
Atestinal Co B. ^ 
Absorption
o/c RETEI'ITIOH
' ------ ---- ------------- 1
1st 1 
Term
2nd
Term
3rd
Term TOTAL
Excretion rate (o/o per day)
30 0.8 9.1 67.0 76.9 0,45
60 0.1 4.7 65.9 70,7 0.24
100 0.1 1.5' 64.6 66.1 0.11
150 0.4 63,1 63,6 0.067
200 0.1 61,5 61.6 0.055
250 - - 59,9 59.9 0,052
TABLE 7.3
Excretion rates observed by Bozian et al (1963).
Patient
condition given
o/o loss per day 
during B^^ therapy
o/o loss per day 
after B^^ therapy
Normal Dietary 0.12 -
Dietary 0.15 “
Dietary 0.09 -
Irrelevant Dietary'' 4* 65/3 id: 0.23 0.21
deseases Dietary 0.21 -
3/1 wk. 0.15 -
7/1 vk. 0.15 0,14
30/4 wk. 0.11 -
Pernicious 30/4 wk. 0.09 0.10
anaemia 45/4 wk. 0.14 0.11
45/4 wk. 0,16 0.11
60/4 wk. 0.17 «
60/4 wk. 0.14 -
60/4 wk. 0.11 -
30/2 wk. 0.13 -
60/2 vk. 0.12 0.12
and a normal subject. Pig 6,1 and Tables 6.3 and 6.4.
7.5 Rate of loss per day and its probable range:
The final rates of loss per day observed by a number of
workers are sumraarised in Table 7.4 with a note of the measurement
technique. The greater part of these data suggest that the range 
of rates of loss is from about 0.1 « 0.3 per cent per day with a 
mean of ale out 0«2 per cent per day. It seems hardly co-incidental 
that the three values significantly lower than the remainder are 
those principally cited as evidence against the assuirption of • 
metabolic equilibrium with respect to excretion. All of the 
technqiues involved directl^^ or indirectly the use of labelled 
vitamin Clearly, it cannot be shown that one range of
excretion rates is right and the other wrong, but it is possible 
to show that one range is more compatible with clinical findings.
7.5.1, Significance of the rate of loss in relation to 
depletion time:
If the clinical synptoras of vitarain B_ deficiency develop as 
soon as the whole body vitamin pool falls below 10 per cent of 
the nomal value, (Heinrich, 1964), then the time required for 
effective depletion•can be calculated using the estimated rate of 
loss, Caaparison can then be made viith the range of about 1 - 8  
years reported (Maclean and Sundberg, 1956, Paulson and Harvey, 1954) 
for the development of the haematological and/or neurological syriiptcms 
of the 3^2 avitaminosis in patients after total gastrectomay.
On the basis of his estimated rate of loss of 0.051 per cent 
per day, Heinrich, 1964, has calculated the depletion time as 1754 days 
of 4.8 years, which apparently is in good agreeiricnt with the range 
quoted above. His calculation, however, is based on the assumption 
of a linear relationship of retention with time, as he simply divides 
90 per cent of the whole body content of (— 0.9 x 5000 jug assumed) 
by the rate of loss per day (=2.55 yiQ'/day on his assumption of a 
whole body content of 5000jag) and obtains 4500/2.55 — 1754 days.
, In fact, the relationship between retention and time is exponential
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TABLE 7.4
Final rates of loss of vitamin
tuthor(s) TECHNIQUE
Final rates of loss 
per cent per dav.
ïizenstein (1959 a and b) Faecal monitoring-tracer 0.09 - 0.22
(izenstein et al (1962) W-B-M- - tracer 0.10
îizenstein et al (1961) W-B#M. - tracer 0-17
hn et al- (1962) W-B-K- - tracer 0.17
.zian et al (1963) (1964) W-B-K* - tracer 0.09 - 0.23
yssel et al (1966) W.B.M. - tracer 0.09 - 0.17
esent work (1967) W-B-l'ï- #. 500 ug labelled 0.09 - 0.19
‘asbeck et al (1958) Faecal and urine monitoring 
- tracer 0.28
onkite et al (1959) do- 0.23
hloesser et al (1958) Liver monitoring - labelled 0.16 - 0.21
a,ss (1958) do­ 0.08 - 0.46
izenstein (1959 c) and 
izenstein et al (1962)
ll on-labelled B . m i c r o - '  
biological and using 
tracer B^^*
0.03
izenstein et al (1964 
and 1966)
Kinetic analysis by 
computer 0.036
inrioh (1964) W-B-M- - tracer 0.051
(or log-linear) and it is necessary to use the basic equation:
^t = e for vjhich, at depletion, At/Ao is assumed to equal 1/lOth.
A
Inserting this value and transposing, the depletion time (t) = InlO
~ 2r303, Heinrich's value of ?w as the fraction per day, = 0.0C051, and
hence^the depletion time — (2.303/0.00051) = 4,520 days = 12.4 years.
This period is much longer than that calculated by the author and than 
the period (1-8 years) quoted above which he also cites in support of 
his calculated depletion time. A similar coxrment was made by Heyssel 
et al (1966). The analogous calculation for the data of Reizenstein 
et al. (1966) suggests that the depletion time would be even longer 
(= 5760 days = 15.9 years).
If a depletion time of 1-8 years is a reasonable estimate, then 
the corresponding range for the rate of loss is about 0.63 per cent 
per day to 0.08 per cent per day. This range is in good agreement 
with that observed by the majority of workers cited in Table 7.4 
while the mean rates of loss of Heinrich and Reizenstein (1964 and 
1966) would seem to be underestimates. A similar conclusion can be 
dravm with less specific assumptions.
If the range of whole-body content of vitamin - an adult
man is about 2000 to 5000 ug (Grasbeck, 1959, Adams, 1962 and Grasbeck, 
Nyberg and Reizenstein, 1958) and in patients vxith pernicious anaemia 
in relapse is about 200 to 500 pg, then the limiting rates of loss 
corresponding to 1 year and 8 years depletion times can be calculated. 
Clearly, subjects with an initial content of 2000 and of 5000 pgs who 
are depleted at 200 jig and 500 jig respectively correspond with Heinrich's 
assimiption of a 10 per cent level as already discussed. However, 
subjects with an initial content of 2000 jig who are depleted at 500 yig 
can provide a rough estimate of the lowest range to be expected. An 
analogous calculation shows that, even with this more favourable 
assumption, the range is only 0.38 - 0.048 per cent per day, so that 
the mean rate of loss obtained by Heinrich (0.051 per cent per day) 
and by Reizenstein and co-workers (0.036 per cent per day) are at the
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lower limit of this range,
7,6 Discussion:
The only direct experimental evidence reported of a difference 
between the rate of excretion from the body of unlabelled and of labelled 
vitamin apparently that of Reizenstein et al. (1962). It has
been argued (Section 2.1) that it is impossible for fundaraental reasons 
to demonstrate a real difference in the experiments described. Further, 
the final rate of loss from a later analysis of the whole-body monitoring 
data (Reizenstein et al 1964 and 1966) is in good agreement with the 
estimated rate of loss of non-labelled B^^* Both of these rates of 
loss, however, are significantly less than those observed by all other 
authors in Table 7.4 with the exception of Heinrich (1964). None of 
the data discussed, including that of Reizenstein et al. and Heinrich, 
supports the suggestion that the rate of excretion is not effectively 
constant even after 250 days or longer. Indeed, the data as a whole 
suggest that it changes little after relatively short times (30 - 60 
days or less).
The higher ranges of excretion rates observed are in remarkable 
agreement with those to be expected from the clinical evidence of 
depletion times following gastrectomy, while the excretion rates 
found by Reizenstein (1959 c), Reizenstein et al. (1954), (1966) 
and Heinrich (1964) are much lower giving depletion times greatly 
in excess of those reported to date. It seems significant that 
it is the data yielding the higher excretion rates which also 
supports the assumption of metabolic equilibrium in a finite 
(and short) period of time at least with respect to the excretion 
of vitamin B^^*
Heinrich (1964) suggests that the higher values obtained by 
Bozian et al (1963) might be due to problems in reproducibility of 
these authors' counting geometry. This is. clearly a gross over­
simplification since Reizenstein et al used an almost identical 
counting geometry wiiile Heinrich's own counting geometry shotfs
■ ■ ■ * _ 6 6 -
increases in the initial counting-rate of over 30 per cent and 
variations in consecutive counts of up to about 10 per cent even 
after 200 days (Fig 1 (b) of Heinrich, 1964). Indeed, it is the 
lower rates of loss tkich are more critically affected by counting 
errors. Substituting the excretion rates of 0.04, 0.1 and 0.2 per 
cent per day in the basic equation At/Ao = e , it can be calculated 
that at 100 days after any chosen reference time, the respective 
counting-rates would be about 96 per cent, 90 per cent and 82 per cent 
of those at the reference time. The uncertainty in estimating a loss 
of only 4 per cent is almost certainly greater than that for losses of 
10 to 20 per cent.
If metabolic equilibrium does not occur in a finite tirae, then, 
presumably, the level of body stores and the size of the administered 
dose will influence the excretion pattern and the rate of loss. In 
anaemic patients, the administered 'Utracer" dose, if sufficiently 
large, may be greater than the total body content before administration. 
Hie behaviour of the tracer may then typify that of natural in 
normal subjects or, at the other extreme, show gross perturbations 
compared with natural B^^ because tlie "steady state" has been 
drastically violated. Bozian et al. (1963) and Keyssel et al, (1966) 
(Table 7.3) found no difference in excretion pattern or rate or loss 
between normal and anaemic subjects with administered doses ranging 
from 3 p.g to 65 jig total. Hie se doses, however, are small compared 
with the total body content even of anaemic patients ( - 200 - 500 u^g 
of vitamin B^^), Intravenous doses of about 5000 jig of labelled 
vitamin B^^ were administered to anaemic patients and a normal subject 
as described in chapter 6. This dose initially is comparable with 
the total body content of a normal subject and about 10-25 times 
greater than that of an anaemic subject. The excretion pattern 
and rates of loss (Pig 6.1 and Tables 6.3 and 6.4) are virtually 
identical for the normal subject and the anaemic subjects and apart 
from a larger initial excretion vhich may be explained by the size 
of the dose, the data are in excellent agreement with those of Bozian,
-  6'6 -
Heyssel and co-workers. Apparently, therefore, neither the size 
of body stores nor of the administered dose influences the general 
excretion pattern, the time at which the excretion rate becomes 
effectively constant or the final value of the excretion rate.
The assumption that metabolic equilibrium is established in a 
comparatively short time may not be the only explanation of these 
findings but, in view of the supporting evidence cited earlier, 
it would seem to be the most likely explanation.
Reizenstein (1966) implies that a kinetic analysis is needed 
"to translate the experimental data (in themselves meaningless) 
into physiologically meaningful terms" in the study of vitamin 
metabolism tdiile only for closed systèms of for single-pool systems 
is the assumption of isotopic equilibrium justified. The kinetic 
analysis of Reizenstein et al (1956), however, shows that over 99 
per cent of the tracer dose of vitamin B^^ contained in a single 
pool; -vdiich would seem to imply that a kinetic analysis is not 
necessary in this case and that, with the arguments presented above, 
the assumption of tracer equilibrium with respect to the excretion of 
vitamin B^^ is a valid approximation in theory as well as in practice.
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CHAPTER 8; In vivo activation analysis of iodine in the 
thyroid - Preliminary studies and their 
Adaptation for Clinical Trials,
8.1 Introduction:
The limitations of the indirect metliods currently used to 
measure the exchangeable iodine content of the thyroid and the 
importcince of knowledge of the intrathyroidal stores of iodine 
have already been discussed (Chapter 1 sections 1.3 and 1.4),
As well as providing a direct method of measurement, in vivo 
activation analysis appears even more suitable for the estimation 
of the elemental content of specific organs than of the total body 
content. In particular, the estimation of iodine in the thyroid 
gland at least has the advantages that the gland is close to the 
surface of the body and the irradiation area is small compared 
\iith. whole-body irradiation. Preliminary experiments were 
conducted using neutrons from the U.T.E. 100 reactor to establish 
vjhether measurements in vivo would be feasible with an acceptable 
radiation dose, subsequently to measure total iodine levels in 
excised glands (Boddy, 1966), The techniques were subsequently 
adapted for clinical trials.
8.2 Preliminary studies:
A horizontal beam tube of the UTS-100 reactor was selected
as the most convenient' facility for preliminary studies. A
collimator with a shutter already existed for this beam tube and
elementary measurements with gold foils suggested that a neutron
7 2flux of at least 10 n/cm sec should be obtainable. As thyroid 
monitoring was not carried out at the Centre, apparatus for this 
specific purpose had not been established and the prototype whole- 
body monitor was the most suitable equipment for measuring the 
induced radioactivity.
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8.2.1 Theoretical considerations:
a) Irradiation and induced radioiodine activity:
An estimate of the specific activity of iodine resulting from 
irradiation of the thyroid by the beam of neutrons was obtained from
s . 0.6
8.7 xlO'^ 'X'"  ”
128where S = specific activity as jio of X per milligram of iodine
2
S c=! effective neutron flux, in neutrons per cm per sec.
O'= activation cross-section of iodine in bams (= 5.6 bams)
A « Atomic Weight of iodine-127 
t = irradiation time.
T = half-life of iodine-128 («25 min)
At the irradiation position^ the thermal neutron flux was 
7 —2 —1approximately 2 x 10 n.cm"* . sec" . For an exposure time of, say, 
five minutes, the specific activity resulting is about 2m jio/mgm.
b) Detection*
The prototype whole-body monitor has a background counting-rate 
of about 40 counts per minute over the main iodine-128 photopeak at 
0.46MeV. Interpolation from results on the 0.51 KeV photopeak of 
sodium-22, suggested that for iodine-128 the counting rate would be 
approximately 4, 640cpm/jic. The 5 min. irradiation produces about 
2mjia/mgm so the counting-rate is about 9*2 cpm /mg. The minimum 
detectable quantity, defined as the amount of iodine giving the same 
number of counts as three times the standard deviation of the background 
in the same counting time, is then about 0,65 mgs. for a 10 minute count.
The interpolation was confirmed by irradiation of ammonium iodide 
under the conditions described produoint approx. 8.8 cpm/mg.I.
8.2.2 Experimental methods :
A water-filled polythene thyroid phantcm was irradiated at the 
biological shield of the UTR-lOO reactor using a collimated beam of 
neutrons from a horizontal beam tube as shown in Fig. 8.1. The
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Figo 80I 0 Ir ra d ia t io n  Position  
H orizonta l Beam Tube
phantom bore either a standard comprising 12 mgs of iodine (as 
ammonium iodide), or an excised human thyroid. Irradiation times 
were varied from 5 - 2 0  minutes and the reactor was operated 
at 100 kW.
Counting was carried out in the prototype ^  ole-body monitor.
The neutron energy spectrum was estimated by the use of criticality 
dosimeters (Dennis J.A, (1964)).
8.2.3» Results;
a) Estimation of iodine content of a human thyroid
Fig. 8.2 shows the gross gamma-ray spectrum frcm an excised 
human thyroid after neutron irradiation for 5 minutes. The spectrum 
clearly shows the principal photopeak of the induced iodine-128 
(0.46MeV) and, less prcaainently the associated peaks at 0.54 MeV,
0.75 MeV and 0.99 MeV.
Peaks due to sodium-24 and chlorine-38 occur at 1.38 and 1.64 MeV 
respectively and there may be less obvious peaks at about 0.8, 1.1 and 
1.27 MeV possibly attributable to copper, magnesium, iron^manganese or 
silicon vjhich are also present, in the thyroid (Health Physics, Vol.3. 
(I960)).
The iodine content of the gland was calculated by comparing the 
area under the 0.46 MeV photopeak with that of the iodine standard 
irradiated and counted under similar conditions. Due allowance was made 
for the contributions of sodium-24 and chlorine-38 in the thyroid's 
photopeak by separately counting a prepared source of each isotope.
The integrated thermal flux to the phantom and thyroid were monitored 
individually with gold foils.
Duplicate measurements were made in vitro on human thyroids 
removed at autopsy. The results are summarised in Table 8.1. The 
iodine content of thyroid I was also measured using a biochemical 
method tihich gave a value of 8.7 mgs.
b) Dosimetry:
The threshold detectors roughly divide the neutron spectrum
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into themal^ intezmedxate (0,12eV-lMeV) approx and fast (IMoV and
7above)- The results corresponding to a thexmal flux of 2 x 10 
2n/caa /sec- and an irradiation time of 1 minute are presented in 
Table 8.2.
The thyroid dose in a 5 minute irradiation will be about 3.2 
rad. With neutron Quality Factors appropriate to acute exposure 
the rem dose is about 5 rems and with prot acted exposure values the 
rem dose is about 18 rems (see 8.4). This last dose^ which is 
similar to that received by the thyroid in clinical diagnostic tests 
involving administration of about 12 ^ cs of iodine-131, is a 
pessimistic value and almost certainly represents an upper limit.
The remainder of the body, being protected to a large extent ' 
by the biological shield of the reactor, would be unlikely to receive 
a dose in excess of 100 millirem during the five minute irradiation.
8-2.4, Discussion:
The duplicate in vivo measurements are in good agreement mutually 
and thyroid I agrees well with the result from biochemical assay.
Biggs (Riggs D.S., (1952)), obtained an iodine content of about 
8 mgs- for the thyroid gland using chemical methods. In vivo tech­
niques with radioisotopes gave a range of 1.3-18.1 mgs of iodine in 
the glands of euthyroid patients (Hodine J.H, et al (1957)) and a range 
of 0.9-22.5 mgs. with a mean of 9mgms. for similar patients (Wayne E.J. 
et al (1964)).
The interference of sodium-24 and chlorine-38 was not a serious 
embarrassment in the in vitro irradiations, and it seemed likely that 
the additional yields of these isotopes in the in vivo studies might 
be offset by their removal in blood.
The technique, however, required some modification before it
could be tested clinically. With a patient, irradiation using the
horizontal beam tube would have been difficult to arrange and make
7 2reproducible. Neutron fluxes of 2 x 10 n/cxa • sec thermal and
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TABLE 8.2
Neutron spectrum and Radiation doses.
Radiation Elux-2 -1 n.cm • seo
Integrated flux | ^ade.n-i. cm^
n. cm
.. i
Rad
dose
.}.. ■ . . .
7Thermal n. j 2 x 10 
Intermediate n. 4«7 % 10^
East n* \ 1,45 % 10^
Gamma | ^x/hr
. ......................... ............ L ,  ______________  .. .
1.2 X 10^
ô
2.8 X 10^ 
8.7 X 10^
_ _  ........
6.30 X 10"11 
3.55 X 10"^° 
3.62 X 10"9
0.075
0.098
0.52
0.15
TABLE 8a3
Approximate estimated doses to remainder of body during irradiation 
at the horizontal beam tube-
Part of body Dose as per cent 
of thyroid dose.
Thyroid 100
Eyes 20 - 30
Gonads 5 - 1 0
Feet
!
1
6 2
4-7 X 10 n/cra - seo Intermediate were only obtainable with the 
reactor at its maximum power, leaving no margin in hand for modifying . 
the flux spectrum and increasing the effective flux without necessarily 
increasing the radiation dose to the gland- These difficulties have 
been overcome to a large extent by the use of the central vertical 
stringer of the reactor as described in Section 8.8-
While the sensitivity of the prototype whole-body monitor was 
remarkably good, the small dimensions of the detector seemed likely 
to lead to difficulties in reproducing the counting geometry with 
patients- Additionally, the heavy commitments of the monitor in 
the whole-body monitoring programmes made allocation of time 
difficult. A shadow shield thyroid monitor was designed and 
constructed (Chapter 9) to provide a suitable counting arrangement 
at least until a large detector could be obtained for the prototype 
whole body monitor and its performance assessed.
In compliance with the requirements of the Site Licence covering 
operation of the UTR reactor, a submission (Boddy, N., Wayne, E-J-, and 
Alexander, W-D-, 1965) was made to the Reactor Safety Committee and 
approval waa granted for clinical measurements in patients,
8-3 Adaptation of the irradiation position;
The central vertical stringer of the reactor has the 
advantages over the horizontal beam tube that the emergent neutron 
flux is about 20 times greater for the same reactor power and re­
producible alignment of the patient is easier.
A collimator, 57in- in length, was constructed of concrete and 
lead in a steel shroud designed to fit closely in the central vertical 
stringer. An aperture 6 in. x 3 in- extends throughout its length.
The aperture dimensions were selected on the basis of physical 
measurements on hospitalised patients (Alexander, W-D- Personal 
communication, 1965). The patient lies on a moveable bed with the 
estimated location of the gland on a neck-rest to predetermine 
position. The bed is moved forward outside of the beam until the 
neck-rest is roughly in line with the aperture, when the bed is moved
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sideways to the irradiation position- A low line of concrete blocks 
defines the final position of the bed and this lining-up procedure 
avoids passing the patient's head and eyes through the emergent beam- 
Fig- 8.3 is a schematic representation of the irradiation position.
8-4 Dosimetry - thyroid gland:
The neutron energy spectrum was again estimated ;d.th threshold 
detectors (Dennis, J.A. 1964) and the results are summarised in Table 
8-4 for a reactor power of 20 kW-
The energy spectrum of the emergent neutrons is "harder", or ' 
contains a larger proportion of neutrons in the intermediate ehergy 
range, than that at the horizontal beam tube (see Table 8,2). This is 
presumably attributable to the smaller amount of moderator between the 
fuel tanks of the reactor and the central vertical stringer- The 
emergent flux per kilowatt of reactor power is about twice as great 
in the thermal and fast regions and about twelve times ' greater in the 
intermediate region-
Before an estimate of the dose in rem can be made it is necessary 
to assume appropriate values for the Quality Factors or R.B-E. The 
threshold detectors roughly divide the neutron spectrum into theimal, 
intermediate (0.12eV - 1 MeV approx.) and fast (1 KeV and above),
(Dennis, J-A., Personal Communication and "Neutron Dosimetry" Vol. I. 
IAEA, 1963). The R-B-E- values for protracted low dose-rato exposures 
are summarised in Table 8.6 (from N-B-S, Handbook 63, "Protection Against 
Neutron Radiation up to 30 KeV"). In the inteimediate region, the 
preponderance of neutrons is presumably in the middle of the energy 
range as the fast and thermal fluxes are about equal- A direct mean 
R-B.E- of about 7 over the six energy groups of Table 8-5 should 
represent a pessimistic value for the R-B.E. In the fast region, 
most neutrons are at the lower end of the range and an R-B.E- of 8 is 
probably a realistic estimate.
On the other hand, the thyroid exposure is short (5 minutes) 
and the dose-rates are large, compared with life-time exposures of 
100 mrem/week as in Table 8.5. It seems more realistic to assume
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TABLE 8.4
Radiation Fln%2
n/cia . sec
Integrated flnx 
for 5 min. exposure 
n/cm
Rads. n  ^cm^ Rad
Dos©
Thermal n 7v4 X 10® 2.2 X 10® 6.30x10"^! 0.14
Inteimediate n 1.2 X lo'^ 3,6 X 10® 8.55x10"^° 1.28
Fast n 6.6 X 10® 2 .0  X 10® 3.62x10"® 0.72
Gamma 1 2.4 rad
U. —». ...... . . . 1 ■ ■ .
2.4
TABLE 8 05
j Thermal region Intermediate region Past region
1 R.B.E. Mev R.B.E. 1 MeV H.B.E.
0.0001 2 2.5 8
0.005 2.5 5.0 7
0.02 5 1 7.5 7
0.1 8 1 10 6.5
1 0.5 10
L _______— ....  _ j 10.5
that the exposure more closely approximates an acute exposure for 
which different values of R.B.E. are applicable (Report of the R.B.E. 
Committee to the International Commission on Radiological Protection 
and on Radiological Units and Measurements, reported in full in 
Health Physics, Vol. 9 pp. 357 - 386, 1963). After discussion of the 
available biological data, the Committee concludes that "a value of 
1 is reasonable for bone marrow failure and associated môxtality. It 
seems probable that the value will be higher, of the order of 2, for 
intestinal injury and its associated mortality". Data for "variously 
degraded fission spectra" and "simulating an uhdergraded fisâion 
spectra" are included in''the rèview. The present spectrum is presumably 
between"these extremes. If the thyroid exposure approximates more 
closely to an acute exposure, then an R.B.E. value of 2 in probably 
pessimistic. The rem doses equivalent to 5 minute exposure at 20 kW 
are summarised in Table 8.6 for protracted and acute R.B.E, values.
The more pessimistic estimate of the dose is about 18 rem and 
probably the more realistic about 7 rem. The higher dose is 
comparable with that from the routing diagnostic thyroid uptake 
test using iodine-131 in *v^ ich about 12 ^ c of iodine-131 is 
administered resulting in a dose of about 17 rem,
8.5 Dosimetry - whole-body:
The neutron dose variation along the length of the body was 
estimated using gold foils placed at intervals along the moveable 
bed. The bed was then placed in the irradiation position for 5 
minutes with the reactor at a power of 20 kW, The gamma dose was 
measured correspondingly, using integrating ionisation chambers and 
by dose-rate measurements with an ionisation chamber. Table 8,7 is 
a summary of the results expressed as percentages of those at the 
mid-line of the neck-rest. The general pattern, as might be expected, 
is similar for both types of radiation. It can be seen that the dose 
to the eyes is unlikely to exceed 10 o/o of the gland dose and the 
gonad dose is less than 1 o/o of the gland dose.
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TABLE 8.6
Radiation Raddose
Protracted exposure Acute exposure
R.B.E. rem dose R.B.E. rem dose
Thermal n. 0.14 5 0.52 2 0.28
Interm ediate n. 1.28 7 8.96 2 2.56
Fast n. . : 0.72 8 ■' 5*76 . 2/ 1.44
Gamma .2 .4 1 2.4 1 2.4
Total = 17.64 Total ss 6*68
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8.6 Doses arising from "the maximum credible accident"-
For reactor safety assessments, "the maximum, credible accident" 
is conventionally defined as the simultaneous occurrence of an operator 
error and two instrument failures. Two cases v^ich probably represent the 
limiting situations of a rapid rise in reactor power and a slow rise in 
reactor power over the five minute irradiation time are:
a) Sudden insertion of the total available reactivity (0.3o/o) - 
operator error; failure of automatic control and variable power 
trip - two instrument failures.
b) Slow power rise lAich is neither noticed nor corrected - 
operator error; failure of autoraatio control and variable power-trip « 
two instrument failures.
Method of calculation:
If the dose-rate at 20 k¥ is D (r/min) then the integrated dose
/I Tut tdue to the excursion is given by : D . « D e ) *=*
ju excursion o Vw o
T t
D (Te ) \diere t mins. is duration of excursion and T mins. is the o o
period.
The reactor power is initially 20 kW and reaches 120 kW before 
the fixed safety channels cause a reactor scram. The power increases 
by a factor of 6, equivalent to about 1.8 periods.
The total dose during a normal irradiation is 5 x rem.
Case a) - sudden insertion of total excess reactivity:
The period resulting from the insertion of 0.3o/o reactivity is 
approximately 6 secs. Taking the limiting period which might not 
trip the period meter of the reactor, causing a scram at 5 seconds 
period, as 5.0001 seconds.
Time to shutdovmi = 1.8 x 5.0001 Shutdown amplifier time ( 1 sec)
= 10.0 seconds approximately.
- “o 0°‘°
60
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£o- (e^"° " = 0.53 X D
12* °
If the excursion occurred at the end of the irradiation time, 
the total dose is 5,58D^ or about 10 percent higher than the 
anticipated dose.
Case b) •* slow rise in power to 120kW during 5 min« irradiation :
1*8 periods = 5 min.
1 period = 2*78 min.
■ “«c.r.io»-
The dose is approximately fourteen times the anticipated steady
dose.
The unrealistic assumptions embodied in both "maximum credible 
accidents" require emphasis. ho mechanism can be'foreseen which 
could lead to the rapid insertion of the total reactivity of the reactor, 
A single experiment controlling 0,3 o/o reactivity would not allow 
criticality. Instantaneous removal of the control rods would 
presumably require a simultaneous explosion at the base of both 
separate fuel tanks giving a thrust in exactly the right direction for 
removal of the rods without causing damage to the tanks and consequent 
loss of moderator. A slow rise in power would be detected outwith the 
"scram" controls of the reactor. Installed wall monitors in the 
Reactor Hall produce audible and visual warnings in the Control Room 
■v^ en a pre-set radiation dose-rate is exceeded. Additionally, the 
clinician and physicist, "vÆio remain close to the irradiation position 
during patient exposure, continuously monitor the radiation levels 
using portable monitors. It is apparent that the "maximum credible 
accidents" are certainly highly improbable.
CHAPTER 9; Development and Performance of a Thyroid Monitor 
of High Sensitivity using a Shadow Shield.
9.1 Introduction:
In the preliminary studios, the prototype monitor was used as 
no facility existed at the Centre for monitoring the thyroid gland. 
Since a collimated detector (for example, Belcher et al. 1964) did 
not appear to have sufficient sensitivity, a shadow-shield thyroid 
monitor was developed capable of measuring a few millimiorocuries 
of iodine-128 in a counting-time of ten minutes. Because of the 
longer half-life of iodine-131 and the similarity of its principal 
gamma ray energy (0.36 MeV) to that of iodine-128 ( 0,46 MeV), this 
isotope was used for all of the preliminary investigations.
9.2 Construction of the Monitor:
The reduction of the background counting-rate of a 3 inch 
diameter x 3 inch sodium iodide detector in the energy range 0.42 - 
0.48 MeV. (pertinent to iodine -128), was investigated with 2 inches 
of lead close to the crystal and also in the shadow-shield monitor. 
Tables 9.1 a and 9.1 b are a summary of the results. The monitor 
was, of necessity, constructed from materials immediately available 
on site and the final design is shoim without the neck-rest in Fig
9,1. Four inch standard lead bricks form a castle, open at the
front, aromid the detector. The detector is "collimated" by two 
sections of a castle, normally producing a simple cylindeiical 
collimator extending 2.3 inches in front of the crystal face, A 
"shadow wall" of four inch lead bricks was constructed 20 inches 
from the crystal face leaving sufficient space for the patient 
to be seated in front of the detector. Using the criterion that 
the centre of the crystal face should be in the "shadow" of the wall. 
Fig. 9.2, the dimensions required for the wall wère calculated by 
elementary geometry to be about 15 inches on each side of the mid-line,
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TABLE 9„1»A
Shield
Condition
cpra in range 
0.42-C„48 KeV
! o/o unshielded 
’ counting rate
1, Unshiolded 522 1 100
2. Castle pieces only around X tal« 210
1
I 40
3. In 4" lead castle with "Collimator" 50.1 j 9.6
4, As 3 with shadow-wall. 22.4 j 4.3
TABLE 9.1.3
Reduction of Background Counting-Rate (0,3 - 0,42 MeV). 
with size of Shadow - Wall and 4 inches collimation.
Shadow Wall Condition
Background 
Count ing-rat e ( cpm)
1. Square of 4 lead bricks 4" thick - 
4" on each side of crystal axis. 76.9
2. Square of 15 bricks - 8" on each 
side of crystal axis 48.7
3. Square of 36 bricks - 12" on each 
side of crystal axis. 49.7
4. Square of 64 bricks - 16" on each 
side of crystal axis
45.0
' é ‘ > i
Figo 9olo Shadow-shield Thyroid Monitor
Fig. 9.2.
SCHEMATIC PLAN OF THYROID M O N ITO R
20
M „ !
3 x 3  No I  
DETECTOR
A 9 
B C  
C O
2-3 
I - 5
20"
BY SIMPLE OEOMETRY. 
ED = 13" APPROX.
This calculation is clearly a gross over-simplification but seems 
justified by its effectiveness in practice (Tables 9. a and 9.b)
9.3 Performance of the thyroid monitor;
The total error in measurements arise from geometrical or 
positional variations and the counting statistics.
a) Geometrical variations:
i) Along the main axis of the crystal:
Ampoules containing 0.68 uc of iodine - 131 were placed in a 
neck phantom at distances of 3% inches to lOj inches from the crystal 
face. The counting-rate in the region of the 0.36 MeV photopeak 
was determined for each position^ using a T.M.C. 401 pulse height 
analyser- The results are summarised in Table 9.2 and shown 
graphically as percentages of the counting-rate at inches from 
the crystal in Fig. 9.3. If it is assumed in the first instance 
that the geometrical uncertainty on this axis due to individual 
differences in the location of the gland or to patient positioning 
is approximately ^ inch, then the percentage variations may be 
roughly estimated by taking the difference from the mean of adjacent 
results. This has been effected in the penultimate column of Table
9.2.
ii) At right angles to the main axis of the crystal:
The location of the gland may vary from person to person across 
the neck as well as in depth. Variations in the horizontal plane 
through the crystal axis were investigated using a single ampoule of 
iodine - 131 at various angles and distances v/ith respect to this 
axis (or reference line).
The results, expressed as percentages of those on the reference 
line at the same perpendicular distances from the crystal face, are 
summarised in Table 9.3 and shovm graphically in Fig. 9.4. If it is 
arbitrarily assumed that this variation may be represented by the 
variation of the counting-rate of a point source at 1" 4% from the 
crystal axis, the variations given in Table 9.%.may be commuted.
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TABLE 9»2
Lstance (inches) 
tram crystal face
j N et 
1 cpm Mean + Variation o/o
Sensitivity (uc) 
in 10 min. count
sè
1
18321
15449 + 2872 4- 18.6
2.9 % 10-4
4i
si
/
12577
9193
10885 ±  1692 
8123 + 1070
4" 15.6
13.2
4,2 X 
5.8 %
10-4
10-4
6i 7052
6316 + 736 ± 11.6
7.5 % 10-4
7ï 5579
5062 + 517 t 10.2
9.5 % 10-4
8i 4544
4127 + 417 ± 10.1
1.2 X 10-2
9ï 3709
3395 + 314
1
± 9.3
1.4 X 10-2
loj- 3081
1 1.7 X 10-2
VARIATION OF COUNTING RATE ALONG CRYSTAL AXIS
lOO
9 0
8 0
7 0
60
5 0
4 0
3 0
20
lO
INCHES FROM CRYSTAL FACE ALONG CRYSTAL AXIS
table 9„3
Angle with respeat 
to crystal axis 
(degrees)
Percentage of counting-rate 
on crystal axis at same 
perpendicular distance frcm 
crystal face.
8*0 100
11*5 100
16.0 95.5
24.0 80
30.0 52.5
34.0 30 j
j 39.0 12.5 1
Fig.
100
IQ
t-
5 .0
19
oc
1 9
4 0 3 0 4 020
OtCREES OFF CRYSTAL AXIS
Fig. 9.4.b.
lOO
1 0
COLLIMATION
7.0
to
U  i£)
% 10
4 —  »—
COLLIMATION
IQ
IDEAL
I AEA
iO
INCHES OFF CRYSTAL AXIS AT 6 - 5  FROM CRYSTAL FACE
b) Sensitivitys
The sensitivity of a counting system may be defined as the 
activity of a given isotope viiich produces a count equal to three 
times the standard deviation of the background count recorded in 
the same counting-time (Trott 1955) « For iodine-181, taking an 
energy range of 0.30-0.42 MeV, the background-rate was 67 counts 
per minute. Using the data presented in Table 9.2 and assuming 
a counting-time of 10 minutes, the sensitivity at each distance 
from the crystal face may be calculated. The results are given 
in the final column of Table 9.2.
9.4 Discussion:
The variation with distance from the crystal face (Table 9.2) is 
largest, as might be anticipated, at the closer distances. At working 
distances of about 5 8/4 inches and greater, the reduction in variation 
m t h  distance is scarcely sufficient to off-set the loss of sensitivity. 
The variation reduces only from about 13a2o/o to 9.3o/o while sensitivity 
worsens by a factor of 8# Variation off the crystal axis at each 
distance is smaller than that along the axis, presumably due to the 
crystal diameter of 3 inches and "nominal" collimation. At 4 inches 
from the crystal face the "off-axis" variation is only 5.3 o/o decreasing 
to zero at just over 6 inches. A working distance of 6.5 inches was 
chosen as the best compromise.
The performance of the monitor may be compared with the recommend­
ations of a Consultants’ Meeting on the Calibration and Standardization 
of Thyroid Radio iodine Uptake Measurements to the I.A.E.A. (Int. of
appl^, Kad. Isotopes 13,167 (1962). The visual field, defined as the
131region within which the count ing - rat e from a point source of I does 
not fall below 90 per cent of the value recorded at the centre of the 
field if the point source is moved at the working distance, should be 
preferably 12 and certainly not greater than 15 cm. in diameter in 
adults and proportionately smaller in children (3*2.1). The count ing­
rate of the monitor falls to 90 o/o at 20^ off the crystal axis and a 
visual field 12 cmx in diameter can be shown by simple geometry to
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coincide with the chosen working distance of 6.5 inches. Although 
this recommendation is satisfactorily met, the coxmting-rate at 
this working distance does not decrease beyond the edge of the visual 
field as rapidly as suggested in the recommendations. At 1.2 and 1.4 
times the radius of the visual field, the counting-rate has fallen to 
only about 81 o/o and 65 o/o respectively compared with the recommended 
values of SO o/o and 5 o/o. This is of minor importance in the in 
vivo studies tdiere neutron irradiation is confined almost entirely 
to the thyroid gland by collimation of the beam and extrathyroidal 
iodine - 128 is unlikely to make a significant contribution.
If the specific activity of iodine-128 induced in the gland is
about 2 mjuc/mg of iodine (Section 8.2.1) then the sensitivity of the
monitor for iodine-128 can be roughly estimated by assuming identical
detection efficiency for the principal gamma rays of iodine-131 (0.36
MeV) and iodine-128 (0.46 MeV). The sensitivity (/ic) for iodine-128
can then be obtained by multiplying the appropriate iodine-131 sensitivity
in Table 9.2 by the ratio of the respective gamma-ray percentage yields
per disintegration (via 80 o/o 17o/o = 4,7). The sensitivity in
milligrams of iodine is then; 4„7 x Sensitivity of iodine-131 (Table 9n2)(muc
2 (mpc/ mg. I)
At about 6 inches from the crystal face, the corresponding sensitivity 
is about 1.5 mg. iodine. This is worse than the prototype monitor by 
about a factor of 2 but is about 12 times more sensitive than the 
diagnostic uptake monitor (Shimmings, J«, Private communication) 
routinely used in the hospital. Reproducibility, with respect to 
the patient-crystal geometry, could be checked more readily than with 
a detector of the same size in the prototype whole-body monitor. The
better sensitivity of the latter makes it the method of choice, particularly 
with a large diameter detector idiere axial alignment is much less critical, 
but, in view of whole-body monitoring committments, its availability was 
limited. The shadow-shield thyroid monitor was consequently used for 
the preliminary clinical trials.
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CHAPTER 10: Clinical Trials of In Vivo Activation Analysis of
Iodine in the Thyroid Gland and Modifications of 
the Technique frcm ‘the Experience Gained*
10.1 Introductions
A preliminary series of clinical trials has been conducted 
to examine the feasibility of the technique in practice and to 
ascertain the problems remaining. Eleven patients vâth non-toxic 
goitre have been examined and the results compared with 'those from 
in vivo measurements of exchangeable iodine using the method of 
Nodine et al, (1957), in vitro activation measurements on the same 
gland following thyroidectomy and biochemical analysis of the excised 
gland.
10.2 Methods and Materials;
a) Analysis of data:
As discussed in Chapters 1 and 8, neutron irradiation is not 
specific in the sense that only the element(s) of interest is 
rendered radioactive. Experience from the preliminary experiements 
suggested that the principal interfering* isotopes, produced incidentally, 
are sodium-24 and chlorine-28, To determine the amount of iodime present 
in the gland involves solving an equation of the forms
T.I.I. (mg) = ^  ^ I_i28 _ f (1 01-38 - f , INa - 24) -
^C1
tdiore T.I.I, =  Total intrathyroidal iodine (mg),
K “ cpm/mg. of iodine,
^ X = Integrated net counting-rate (cpm) in photopeak of isotope X 
fy/^ “ Fractional Compton scatter coefficient of isotope X 
in photopeak of isotope y, 
viz- fy/^ ^ Compton contribution of isotope x to the photopeak
energy region of isotope y.
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Clearly, if other isotopes also make a significant contribution 
in the iodine - 128 photopeak region, further corresponding terms 
must be included,
b) Experimental procedure:
The irradiation situation described in section 8,3 and the 
shadow-shield thyroid monitor (chapter 9) were used, A five inches 
diameter x five inches detector, kindly loaned by Quartz et Silice,
Paris, was available for part of the trials.
For all patients, but the first, an initial background count of 
10, min, duration was made, v/hich permitted adjustment of the chair 
height to align the thyroid gland of the individual patient with the 
neck-rest (crystal mid-line) and vhich ensured that the gland does 
not contain residual iodine-131 from uptake or similar tests. The 
short half-life of iodine-128 (25 min) and the small quantity of iodine- 
128 induced imply that preparations and adjustments such as these should 
be as complete as possible before irradiation.
Following the background measurement, a small gold foil v/as 
attached by adhesive tape to each side of the neck over the estimated 
position of each lobe of the thyroid. The neutron dose %vas estimated 
by counting the foils in a low-background beta counter. Irradiation 
times of five minutes at a reactor power of 20 k¥ were used. The 
monitoring foils were removed after irradiation and from 1 to 3 
measurements were made of the induced radioactivity. A standard 
sample, containing a known amount of iodine, and others containing 
sodium carbonate and ammonium chloride, were irradiated and monitored 
in an identical manner. The iodine content of the excised glands 
of three patients has been estimated by biochemical analysis and, on 
two of these glands, by in vitro activation analysis.
It was assumed, for the first patient that her background 
counting rate would be closely similar to that of careful phantom 
measurements and, in view of other circumstances, this initial 
measurement was dispensed with. That the assumption was erroneous
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became obvious in the first post-irradiation measurement when a 
sraoll amount of residual iodine-131 could be detected which 
obscured the iodine-128 contribution after the first measurement.
A rough estiraate of the total iodine content of the gland could 
still be made as shown in Table 10.1«
The in vivo results for eight of the patients are presented 
in Table 10«2 along with estimates of the exchangeable iodine using 
Nodine’s method, or of the total iodine content from biochemical 
analysis of the gland following thyroidectomy.
Table 10*3 is a summary of the in vivo activation analysis 
measurements for the two remaining patients, the in vitro activation 
analysis measurements on *bhe glands following thyroidectomy and the 
results of biochemical analysis on the excised glands*
10.4 Discussion:
a) Comparison of activation analysis measurements with those
using other methods and the possible significance of differences 
in the results:
The,.estimated range of the iodine content of the thyroid 
gland was suggested (see 8.2,4) as about 0.9 - 22aS mg. The results 
of in vivo activation analysis all fall within these limits (range 
2.8 - 14.4 mg)«
With the exception of patient B, all of the activation analysis 
results are greater than those from Nodino.’s method. This is to be 
expected since the present method measures the total iodine content 
vhile that of Nodine measures only the exchangeable iodine. Further 
the ratio of total to exchangeable iodine is not constant which, if 
this finding is confirmed, implies that the measurement of exchangeable 
iodine gives no information relating to the total iodine content. The 
assumption of a mean level of intrathyroidal stores is clearly not 
justified so that the iodine-131 uptake test would appear to be entirely 
empirical, at least in the present patients.
The in vivo and in vitro activation analysis results for patients
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G and Ha (Table 10«3) are in good agreement bearing in mind that 
about 75 - 90 o/o of the gland is removed in thyroidectomy.
Consequently^ the in vitro activation analysis result and that of 
biochanioal analysis should always be proportionately less than the 
in vivo result. The foil correction factor is unusually large for 
patient Ha but this was not entirely unexpected as "the patient was 
knovm to have moved during irradiation. Nevertheless, the in vivo 
result is compatible witli the in vitro estimates on the excised gland. 
Excellent agreement vjas obtained between the in vivo, in vitro and 
biochemical analysis results for patient G. The agreement between the 
results of in vivo activation analysis and biochemical analysis is 
reasonable also for patient Mic. (Table 10.%) since, again, the complete 
gland was not removed. Although the results of both activation methods 
are in good agreement for patient Ha, biochemical analysis produced 
significantly smaller estimates which were mutually in excellent agree­
ment. The possible reasons for this discrepancy have been investigated,
b) Experimental difficulties and sources of error:
If biochemical analysis underestimates the iodine content, the 
two most probable explanations might be incomplete oxidation of the 
tissue so that all of the iodine is not liberated or iodine losses 
in dilution, etc. Both causes have been examined v/ith negative 
findings, although an additional oxidation stage produced an increase 
in one result of about 7 o/o«
Experience m t h  the in vivo activation analysis technique 
showed that the effect of 'the emergent beam and residual radiation 
from the central vertical stringer of 'the reactor on the monitor 
background was more pronounced than vdien using the horizontal beam 
tube. This may be accounted for almost entirely by the absence 
of a beara trap v^ich would have been difficult to arrange and would • 
have increased’the patient dose because of baok-scatter. The 
conditions were examined for each in vivo measurement to determine 
the appropriate background counting-rate as far as possible.
The advantage of the higher counting-rates obtained with the 
5 inches x 5 inches detector was off-set to sane extent by gain 
drift shoxm to be associated with the photomultiplier. Since 
the principal photopeak of iodixae-128 has an energy of 0.46 MeV 
which is close to the annihilation peak at Oc51 MeV, gain stability 
is very important and merits even more attention than it received in 
the present studies.
The interference of sodium-24 and chlorine-38 was not a 
serious problem but it was clearly a source of error vhich could 
be diminished if the quantities of these isotopes could be 
reduced (see 10.5)o
The estimated quantities of total iodine appear too great 
from in vivo measurements compared with biochemical analysis*
Standards were checked for reproducibility* The gland was 
unlikely to have smaller dimensions than the ampoules used for 
the standards and comparison with the excised glands confirmed 
this conclusion. Neutron flux depression due to self-shielding 
would consequently be less for the standard and should lead to an 
under-estimate rather than an overestimate of the iodine content* 
Positioning of the phantom containing the standard in the emergent 
collimated beam could obviously be achieved more precisely and easily 
than could the patientas gland* A reduced neutron exposure of the 
patientas gland, however, would again yield an underestimate of its 
iodine content* Similarly, positioning of the patient at the monitor 
would lead to a low value* The only likely cause of an over-estimate 
of the gland *s content appears to be contributions in the iodine-128 
photopeak from incidental isotopes apart from sodium-24 and chlorine- 
38 for which allowance is already made* The gross spectrum of patient 
H is shown in Pig* 10*1 and inspection has failed to suggest vÆiat, if 
any, other isotopes may be contributing significantly* At the present 
time, no single factor can bo cited as the principal cause of the 
difference in the estimates from the activation and biochemical analyses,
10a5 Subsequent improvements in the techniques
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a) Reduction of the post«irradiation dose-ratess
A lead plug has been specially designed and constructed to 
fit the collimator- The plug, some eight inches deep, can easily 
bo inserted, using the reactor crane, during ‘fche transit time of 
the patient to the monitor-
b) Modification of the neutron spectrum:
Examination of the variation of the iodine«127 neutron capture 
cross-section with neutron energy shows that large resonances occur 
between about 0«1 eV and 100 eV which presumably make a highly 
significant contribution to the total iodine«128 produced on 
irradiation- Sodium and chlorine cross«sections do not have 
equivalent resonances and the majority of induced sodium-24 and 
chlorine«38 is due to neutrons in the thermal energy region- A 
simple method of modifying the neutron spectrum to take advantage 
of the differences in cross-section behaviour appeared to be that 
of introducing an absorber, such as cadmium or boron, which is "black", 
or has a huge capture cross-section, for neutrons of thermal energies"' 
but for which the "cut-off", or fall in cross-section, is extremely 
rapid at about 0-1''eV« Studies have been carried out to test the 
effectiveness of this procedure-
Standard samples containing iodine or sbdiura or chlorine were 
prepared- A standard of each element was irradiated, using the 
collimator, by the unmodified neutron spectrum and then with a 
cadrriura absorber in the beam and then a boron absorber- The 
counting-rates, in the appropriate photopeak energy ranges, were 
measured using the shadow-shield thyroid monitor- The results are 
summarised in Table 10-4-
It can be seen that, as predicted, the amount of iodine-128 
induced is affected much less significantly than the amounts of 
chlorine-38 and sodium « 24 vjhich are reduced to about 10 - 20 o/o 
of the amounts produced using the unmodified spectrum- If the 
"advantage factor" for each absorber is assumed to be the counting-
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rate of iodine-128 expressed as a percentage of the counting-rate 
m t h  the unmodified spectrum divided by the equivalent percentage 
for each of the other isotopes, then boron is slightly better than 
cadmium but it also reduces the iodine-128 counting-rate to a 
g*reater extent* Ihis latter feature needs careful consideration 
since it involves a greater sacrifice in sensitivityo In view of the 
promise of this procedure, its effect on the neutron spectrum, and hence 
the radiation doses, was examined using threshold detectors (Dennis, 
J*A«, 1964), The results are summarised in Table 10.5 with the 
corresponding neutron doses* The thermal neutron flux is reduced 
to a negligivle level with cadmium and boron absorbers in the 
emergent beam» However, the total neutron dose is not greatly 
reduced. Excellent agreement was obtained with the threshold 
detector measurements' of neutron dose and confirmatory measurements 
using a REH counter (ihaderson, I=0« and Braun, 1963). This counter 
reads in rem units using protracted low-level R.B.E.s, At a reactor 
power of 100 watts and with boron or cadmium in the beam, the corrected 
dose-rate was Ob83 rem/hr* The corresponding integrated dose for a
five minute exposure at 20 is 13,8 rera,
c) Konitoring technique;
In response to a grant application, the Hospital Endoi/jments 
Research Trust has kindly agreed to provide a sodium iodide detector
assembly 11^ inches diameter x 4 inches for the prototype monitor.
Consequently, the monitoring time per patient will be reduced* If 
the availability of MEELIK off-sets the anticipated increase in the 
body-monitoring prograitime of the prototype monitor, then it should 
be possible to utilise the monitor in the in vivo activation analysis 
studies also. In anticipation, preliminary measurements were made
using KERLÏîï, VJith the monitor in the scanning-bed geometry and
the detector protruding through the steel plate (by 1 3/4 inches), 
a lead wall was constructed across the monitor to reduce the back­
ground counting ratOo S-tandards containing 10 mg«, 5 mg«, and 1 
mg,, of iodine were irradiated and monitored. The mean counting- 
rate per milligram of iodine was 28 cpm/mg. and the background
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cotmting-rate was about 190 cpm* The sensitivity (Trott, 1955) for 
a counting'-time of 10 minutes is then about 0*46 mg, of iodine- This 
is significantly better than the thyroid monitor and, with the larger 
detector, off-axial reproducibility should not prove to be a problem.
10s 5 Srmoïiary;
The preliminary clinical trials have shown the feasibility of 
the technique and significant improvements have been made in the light 
of this experience and subsequent experimentation. With delivery of 
the second large detector, further in vitro measurements on excised 
glaTids followed by biochemical analysis are proposed* The cause(s) 
of the small, but significant, difference observed in the iodine 
content as estimated by the two methods may then be apparent or 
eliminated. Satisfactory conclusion of these investigations will 
be followed by the clinical application of the technique. ->
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A«1 Introduction:
Elementary theoretical calculation of the initial KEHLIE shielding.
The construction and performance of the protot;^ 'pe monitor led 
to the conclusion that the shield weight was excessive as the final 
stages of the base and walls provided little further reduction in 
the background counting-rate* It was apparent that the shielding 
in the vicinity of.the detector was of principal importance. A 
fairly complicated and rigorous theoretical treatment, aimed at 
optimising the shield for MERLIN seemed scarcely justifiable in 
view of the experimental approach for the prototype shield and 
the amount of data, and possibly computer time, likely to be 
needed in a sophisticated analysis. Consequent1y, a highly
approximate, but reasonabl3^ effective, "line of vision" analysis 
was developed the fundamental assumptiohs of which were that the 
centre of the detector face could "see" incoming garmaa rays only 
after their passage through the chOs en "thickness of lead and that, 
secondly, gamma rays reaching the detector travelled in straight 
lines to do so* The first assumption is clearly a gross oversimpli­
fication of the conditions in which an optimum is approached while 
the second assumption is strictly applicable only for those gamma 
rays passing through the shield mthout being scattered» The 
principal justification of the analysis is the surprisingly good 
agreement between the results it yields and those obtained 
experimentally (for exaraple, Cliapter 9, Tables 9.1 «A and 9.1.B), 
vhile the mathematics it employs are extremely elementary.
The criterion was adopted of an "effective" thickness of lead, 
of 5 inches, with the exception of the turret where the weight increase 
(from 4 inches thickness) and the complexity of construction were impracticable,.
STEEL PLATE
Fie A.
LEAD BASE
A (crystal ctnfrt)
K
C BASE
FIG A.2
A (crystal centre)
WALL
BASE
FIG A.3
RYSTAL
FIG A.4
A (crystal centre)
PLAN VIEW
FIG A.5
Aa2 a Crystal height in steel plate:
The steel supporting plate provides "colligation" or a partial 
shieldo In accordance vdth above criteria? the height of the 
crystal face above the base of the steel plate should be such that 
the centre of the crystal cannot "see" beyond^ or is in the "shadow" 
of the base* This situation is ùhovjh scheraatically in Fig. TA.1. 
Assuming that a lead base of a total length of 12 ft« is adequate.
then;
a
u a
CK = 72"
CB “ AD'= Crystal radius = 5o75"
BE = 66.25"
FB = 14" (As in the prototype monitor)
a% DF = PB % AD = 14 % 5,75 = 1.22"
tAClR* I "I 'irr
BE 66.25
Required height above base of steel plate — 1.22".
A.3» Base equivalent to six inches of lead:
Although the actual thickness of the base may be only 4 inches 
or 2 inches of lead, the "effective" oblique thickness at some
distance along the base is 6 inches'{see Figs. A.2 and A.3.). The
thickness of the base directly beneath the detector must be six 
inches but at these distances the actual thickness can be reduced 
to 4 inches and 2 inches thus saving shield weight, vjhile the 
"effective" thickness is never less than 6 inches.
The limiting positions are i) the centre line of the base and 
ii) at the outer wall.
i) On centre line of base (Fig-. Ao2) ,
. AG = Crystal face to floor = .18"
ABC = Crystal face to top of basé — 18" « 4" or 2".
FG == Base thickness = 4" or 2"«
FS = "Equivalent" thickhess
KE ™ Distance at'which base thickness can be reduced,
f SO
GE = (PE% - Pcf)3
and KF =  ^  X GE 
PG
Hence for 4" base, KF = 17" 
and for 2" base, KF = 49"
ii) At outer wall (Fig« A.3*)
BG = Half base widüi = 12"
Œ  = Actual base thicknesâ (4" or 2")
FH = "Equivalent" thickness ='6"
MO =
Q4 = AC X MO
2 2 i-Ei = (csyr « BG and ÎM = m  x m
m
so that BP = required distance = Hi « PM
Hence for 4" base, BP = 14-^ " 
and for 2" base, BP = 48"'
This difference bctwoen the distances in the two cases is small, 
amounting to a saving of only about 3 of the four inches standard
bricks. To attem.pt to "stagger" the bricks was, therefore, not
considered worthvtiile«
Ao4o Wall height : (Fig* A«4„)
With the crystal at the calculated height above the base of the 
supporting plate, the distances for wall heights over vihich the 
ciq'-stal face centre cannot "see" were computed as follows:
AB = Crystal ht. above top of wall == (19«22 -h:)"
EF = Ciystal ht « above base of plate = 1«22"  ^'
AE = Crystal radius ~ Oo75"
AC = Half base mdth = 12"'
BD = AB •V- zn? '
and CD = (BCr -!- BCr)3
Ao 5 sa Wall thickness; (Pig« A.5)
The most pessimistic calculation of the distances at which the 
path leng~ths through 4" and 2" wall 'thicknesses are equal to 6" is 
made by assiming a constant wall height equal to that of the crystals 
All positions of the wall, other 'than the top, then have an equivalent 
thickness greater than 6" and the weight difference compared with 
distances for mid-wall of base of wall are again trivial*
AB = HaIf base width = 12"
BC = EG = Actual wall thickness
FE == Equivalent thickness = 6"
FG = (FE^ . F
and BF = FG X AB
GE ■
1
Thickness i Distance j
4" i 13o4" I
2« ' 33c9" I
A«6 a Summary:
4" or 2"
The shield based on these calculations is shorn diagrammatically 
in Fig. 3»1. Tenders were requested for this configuration but 
with maximum flexibility for subsequent modification.
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